Anders Wimo

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: VALUE IN HEALTH. 2024;26(12):S419
IPECAD MODELING WORKSHOP 2023 CROSS COMPARISON CHALLENGE ON COST-EFFECTIVENESS MODELS IN ALZHEIMER'S DISEASE AND RELATED DEMENTIAS
Handels R; Herring W; Kamgar F; Gustavsson A; Skoldunger A; Wimo A; Tate A; Winblad B; Stellick CB; Bruck C; Green C; de Kok I; Hlavka J; Mar J; Urbich M; Soto-Gordoa M; Pemberton-Ross P; Aye S; Jonsson L
Article: VALUE IN HEALTH. 2024;:S1098-3015(24)02790-6
New International Pharmaco-Economic Collaboration on Alzheimer's Disease (IPECAD) Open-Source Model Framework for the Health Technology Assessment of Early Alzheimer's Disease Treatment: Development and Use Cases.
Handels R; Herring WL; Grimm S; Sköldunger A; Winblad B; Wimo A; Jönsson L
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2024;39(7):e6126
Costs of diagnosing early Alzheimer's disease in three European memory clinic settings: Results from the precision medicine in Alzheimer's disease project
Wimo A; Kirsebom B-E; Timon-Reina S; Vromen E; Selnes P; Bon J; Emersic A; Kramberger MG; Speh A; Visser PJ; Winblad B; Fladby T
Article: BMC MEDICINE. 2024;22(1):236
Validation of the Health Assessment Tool (HAT) based on four aging cohorts from the Swedish National study on Aging and Care
Abbadi A; Kokoroskos E; Stamets M; Vetrano DL; Orsini N; Elmstahl S; Fagerstrom C; Wimo A; Skoldunger A; Berglund JS; Olsson CB; Wachtler C; Fratiglioni L; Calderon-Larranaga A
Article: THE LANCET. HEALTHY LONGEVITY. 2024;5(6):e431-e442
Prevention of dementia using mobile phone applications (PRODEMOS): a multinational, randomised, controlled effectiveness-implementation trial
van Charante EPM; Hoevenaar-Blom MP; Song M; Andrieu S; Barnes L; Birck C; Brooks R; Coley N; Eggink E; Georges J; Hafdi M; van Gool WA; Handels R; Hou H; Lyu J; Niu Y; Song L; Wang W; Wang Y; Wimo A; Yu Y; Zhang J; Zhang W; Brayne C; Wang W; Richard E
Article: ALZHEIMERS RESEARCH & THERAPY. 2024;16(1):118
Integrating a multimodal lifestyle intervention with medical food in prodromal Alzheimer's disease: the MIND-AD_mini randomized controlled trial
Thunborg C; Wang R; Rosenberg A; Sindi S; Andersen P; Andrieu S; Broersen LM; Coley N; Couderc C; Duval CZ; Faxen-Irving G; Hagman G; Hallikainen M; Hakansson K; Kekkonen E; Lehtisalo J; Levak N; Mangialasche F; Pantel J; Rydstrom A; Stigsdotter-Neely A; Wimo A; Ngandu T; Soininen H; Hartmann T; Solomon A; Kivipelto M
Article: JOURNAL OF ALZHEIMERS DISEASE. 2024;99(2):471-476
Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer's Disease Treatment
Zupanic E; Emersic A; Wimo A; Winblad B; Speh A; Kramberger MG
Article: ALZHEIMERS & DEMENTIA. 2024;20(2):809-818
Predicting sojourn times across dementia disease stages, institutionalization, and mortality
Tate AE; Bouteloup V; van Maurik IS; Jean D; Mank A; Speh A; Boilet V; van Harten A; Eriksdotter M; Wimo A; Dufouil C; van der Flier WM; Joensson L
Article: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2024;11(1):155-161
Estimates of Current Capacity for Diagnosing Alzheimer's Disease in Sweden and the Need to Expand Specialist Numbers
Mattke S; Gustavsson A; Jacobs L; Kern S; Palmqvist S; Eriksdotter M; Skoog I; Winblad B; Wimo A; Jonsson L
Journal article: ALZHEIMERS & DEMENTIA. 2023;19(S21)
Cost‐effectiveness of amyloid‐targeting therapies: modelling based on 5724 biomarker positive AD patients in the Swedish Registry of Cognitive Disorders
Jönsson L; Skillback T; Kern S; Winblad B; Blennow K; Eriksdotter M; Zetterberg H; Wimo A
Journal article: ALZHEIMERS & DEMENTIA. 2023;19(S22)
Predicting Sojourn Times across Dementia Disease Stages, Institutionalization, and Mortality
Tate A; Bouteloup V; van Maurik IS; Mank A; Speh A; Eriksdotter M; Wimo A; Dufouil C; van der Flier WM; Jönsson L
Journal article: VALUE IN HEALTH. 2023;26(12):s419
MSR136 IPECAD Modeling Workshop 2023 Cross Comparison Challenge on Cost-Effectiveness Models in Alzheimer's Disease and Related Dementias
Handels R; Herring W; Kamgar F; Gustavsson A; Skoldunger A; Wimo A; Tate A; Winblad B; Stellick CB; Bruck C; Green C; de Kok I; Hlavka J; Mar J; Urbich M; Soto-Gordoa M; Pemberton-Ross P; Aye S; Jönsson L; Participants W
Article: LAKARTIDNINGEN. 2023;120:23062
Träning och protein för funktion och självtillit.
Boström A-M; Faxén-Irving G; Franzén E; Grönstedt H; Seiger Å; Vikström S; Wimo A; Cederholm T
Article: ALZHEIMERS RESEARCH & THERAPY. 2023;15(1):200
Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis
Aye S; Bouteloup V; Tate A; Wimo A; Handels R; Jean D; Winblad B; Joensson L
Article: ALZHEIMERS & DEMENTIA. 2023;19(7):2865-2873
The worldwide costs of dementia in 2019
Wimo A; Seeher K; Cataldi R; Cyhlarova E; Dielemann JL; Frisell O; Guerchet M; Jonsson L; Malaha AK; Nichols E; Pedroza P; Prince M; Knapp M; Dua T
Article: LANCET REGIONAL HEALTH-EUROPE. 2023;29:100657
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
Joensson L; Wimo A; Handels R; Johansson G; Boada M; Engelborghs S; Froelich L; Jessen F; Kehoe PG; Kramberger M; de Mendon A; Ousset PJ; Scarmeas N; Visser PJ; Waldemar G; Winblad B
Article: ALZHEIMERS & DEMENTIA. 2023;19(5):1800-1820
Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challenge
Handels RLH; Green C; Gustavsson A; Herring WL; Winblad B; Wimo A; Skoldunger A; Karlsson A; Anderson R; Belger M; Bruck C; Espinosa R; Hlavka JP; Jutkowitz E; Lin P-J; Mendez ML; Mar J; Shewmaker P; Spackman E; Tafazzoli A; Tysinger B; Jonsson L
Article: ALZHEIMERS & DEMENTIA. 2023;19(3):999-1008
Dementia prevention: The potential long-term cost-effectiveness of the FINGER prevention program
Wimo A; Handels R; Antikainen R; Eriksdotter M; Jonsson L; Knapp M; Kulmala J; Laatikainen T; Lehtisalo J; Peltonen M; Skoldunger A; Soininen H; Solomon A; Strandberg T; Tuomilehto J; Ngandu T; Kivipelto M
Article: JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH. 2023;77(2):125-132
Variability in perceived burden and health trajectories among older caregivers: a population-based study in Sweden
Kirvalidze M; Beridze G; Wimo A; Morin L; Calderon-Larranaga A
Journal article: US NEUROLOGY. 2023;19(1):14
Lecanemab: The Price of a Breakthrough
Wimo A; Jönsson L; Johansson G; Winblad B
Article: FRONTIERS IN NEUROLOGY. 2023;14:1175922
Precision medicine in neurodegeneration: the IHI-PROMINENT project
Tate A; Suarez-Calvet M; Ekelund M; Eriksson S; Eriksdotter MM; Van der Flier W; Georges J; Kivipelto MG; Kramberger M; Lindgren P; Lopez JDG; Lotjonen J; Persson S; Pla S; Solomon A; Thurfjell L; Wimo A; Winblad B; Jonsson L
Journal article: ALZHEIMERS & DEMENTIA. 2022;18(S11)
Costs of dementia in Europe: a systematic literature review and meta‐analysis
Jönsson L; Frisell O; Wimo A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2022;89(2):623-632
Association Between Cognition, Health Related Quality of Life, and Costs in a Population at Risk for Cognitive Decline
Janssen N; Handels RL; Wimo A; Antikainen R; Laatikainen T; Soininen H; Strandberg T; Tuomilehto J; Kivipelto M; Evers SMAA; Verhey FRJ; Ngandu T
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2022;50(6):748-755
Changes in mortality trends amongst common diseases during the COVID-19 pandemic in Sweden
Axenhus M; Schedin-Weiss S; Winblad B; Wimo A
Article: ALZHEIMERS & DEMENTIA. 2022;18(6):1119-1127
Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project
Boada M; Rodrigo A; Jessen F; Wimblad B; Kramberger M; Visser PJ; Simo R; Rodriguez-Gomez O; Ciudin A; Georges J; Dumas A; Maguire P; Krivec D; Wimo A; Valero S; Alegret M; Jamilis L; Zwan M; Sannemann L; Arrufat J; Stomrud E; Johansson G; Shering C; Glaysher B; Stewart N; Belger M; Iradier F; Campo L
Article: ZDRAVSTVENO VARSTVO. 2022;61(2):76-84
Cost of diagnosing and treating cognitive complaints: One-year cost-evaluation study in a patient cohort from a Slovenian memory clinic
Zupanic E; Wimo A; Winblad B; Gregoric Kramberger M
Article: BMC GERIATRICS. 2022;22(1):365
Changes in dementia diagnoses in Sweden during the COVID-19 pandemic
Axenhus M; Schedin-Weiss S; Tjernberg L; Wimo A; Eriksdotter M; Bucht G; Winblad B
Article: ECLINICALMEDICINE. 2022;45:101337
Global and regional spending on dementia care from 2000-2019 and expected future health spending scenarios from 2020-2050: An economic modelling exercise
Pedroza P; Miller-Petrie MK; Chen C; Chakrabarti S; Chapin A; Hay S; Tsakalos G; Wimo A; Dieleman JL
Journal article: BMJ OPEN. 2022;12(2):e055984
Attitudes and views on healthy lifestyle interventions for the prevention of dementia and cardiovascular disease among older people with low socioeconomic status: a qualitative study in the Netherlands.
Eggink E; Hafdi M; Hoevenaar-Blom MP; Richard E; Moll van Charante EP; PRODEMOS-consortium
Article: LANCET PUBLIC HEALTH. 2022;7(2):e105-e125
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.
GBD 2019 Dementia Forecasting Collaborators
Journal article: LANCET PUBLIC HEALTH. 2022;7(2):E105-E125
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
Nichols E; Steinmetz JD; Vollset SE; Fukutaki K; Chalek J; Abd-Allah F; Abdoli A; Abualhasan A; Abu-Gharbieh E; Akram TT; Al Hamad H; Alahdab F; Alanezi FM; Alipour V; Almustanyir S; Amu H; Ansari I; Arabloo J; Ashraf T; Astell-Burt T; Ayano G; Ayuso-Mateos JL; Baig AA; Barnett A; Barrow A; Baune BT; Bejot Y; Bezabhe WMM; Bezabih YM; Bhagavathula AS; Bhaskar S; Bhattacharyya K; Bijani A; Biswas A; Bolla SR; Boloor A; Brayne C; Brenner H; Burkart K; Burns RA; Camera LA; Cao C; Carvalho F; Castro-de-Araujo LFS; Catala-Lopez F; Cerin E; Chavan PP; Cherbuin N; Chu D-T; Costa VM; Couto RAS; Dadras O; Dai X; Dandona L; Dandona R; De La Cruz-Gongora V; Dhamnetiya D; da Silva DD; Diaz D; Douiri A; Edvardsson D; Ekholuenetale M; El Sayed I; El-Jaafary SI; Eskandari K; Eskandarieh S; Esmaeilnejad S; Fares J; Faro A; Farooque U; Feigin VL; Feng X; Fereshtehnejad S-M; Fernandes E; Ferrara P; Filip I; Fillit H; Fischer F; Gaidhane S; Galluzzo L; Ghashghaee A; Ghith N; Gialluisi A; Gilani SA; Glavan I-R; Gnedovskaya EV; Golechha M; Gupta R; Gupta VB; Gupta VK; Haider MR; Hall BJ; Hamidi S; Hanif A; Hankey GJ; Haque S; Hartono RK; Hasaballah AI; Hasan MT; Hassan A; Hay SI; Hayat K; Hegazy MI; Heidari G; Heidari-Soureshjani R; Herteliu C; Househ M; Hussain R; Hwang B-F; Iacoviello L; Iavicoli I; Ilesanmi OS; Ilic IM; Ilic MD; Irvani SSN; Iso H; Iwagami M; Jabbarinejad R; Jacob L; Jain V; Jayapal SK; Jayawardena R; Jha RP; Jonas JB; Joseph N; Kalani R; Kandel A; Kandel H; Karch A; Kasa AS; Kassie GM; Keshavarz P; Khan MAB; Khatib MN; Khoja TAM; Khubchandani J; Kim MS; Kim YJ; Kisa A; Kisa S; Kivimaki M; Koroshetz WJ; Koyanagi A; Kumar GA; Kumar M; Lak HM; Leonardi M; Li B; Lim SS; Liu X; Liu Y; Logroscino G; Lorkowski S; Lucchetti G; Saute RL; Magnani FG; Malik AA; Massano J; Mehndiratta MM; Menezes RG; Meretoja A; Mohajer B; Ibrahim NM; Mohammad Y; Mohammed A; Mokdad AH; Mondello S; Moni MA; Moniruzzaman M; Mossie TB; Nagel G; Naveed M; Nayak VC; Kandel SN; Nguyen TH; Oancea B; Otstavnov N; Otstavnov SS; Owolabi MO; Panda-Jonas S; Kan FP; Pasovic M; Patel UK; Pathak M; Peres MFP; Perianayagam A; Peterson CB; Phillips MR; Pinheiro M; Piradov MA; Pond CD; Potashman MH; Pottoo FH; Prada SI; Radfar A; Raggi A; Rahim F; Rahman M; Ram P; Ranasinghe P; Rawaf DL; Rawaf S; Rezaei N; Rezapour A; Robinson SR; Romoli M; Roshandel G; Sahathevan R; Sahebkar A; Sahraian MA; Sathian B; Sattin D; Sawhney M; Saylan M; Schiavolin S; Seylani A; Sha F; Shaikh MA; Shaji KS; Shannawaz M; Shetty JK; Shigematsu M; Shin JI; Shiri R; Santos Silva DA; Silva JP; Silva R; Singh JA; Skryabin VY; Skryabina AA; Smith AE; Soshnikov S; Spurlock EE; Stein DJ; Sun J; Tabares-Seisdedos R; Thakur B; Timalsina B; Tovani-Palone MR; Bach XT; Tsegaye GW; Tahbaz SV; Valdez PR; Venketasubramanian N; Vlassov V; Giang TV; Linh GV; Wang Y-P; Wimo A; Winkler AS; Yadav L; Jabbari SHY; Yamagishi K; Yang L; Yano Y; Yonemoto N; Yu C; Yunusa I; Zadey S; Zastrozhin MS; Zastrozhina A; Zhang Z-J; Murray CJL; Vos T
Article: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2022;9(1):30-39
Multimodal Preventive Trial for Alzheimer's Disease: MIND-ADmini Pilot Trial Study Design and Progress
Sindi S; Thunborg C; Rosenberg A; Andersen P; Andrieu S; Broersen LM; Coley N; Couderc C; Duval CZ; Faxen-Irving G; Hagman G; Hallikainen M; Hakansson K; Lehtisalo J; Levak N; Mangialasche F; Pantel J; Kekkonen E; Rydstrom A; Stigsdotter-Neely A; Wimo A; Ngandu T; Soininen H; Hartmann T; Solomon A; Kivipelto M
Article: JOURNAL OF MULTIDISCIPLINARY HEALTHCARE. 2022;15:2615-2622
Factors Associated with Health-Related Quality of Life in Older Persons Residing in Nursing Homes
Bostrom A-M; Cederholm T; Faxen-Irving G; Franzen E; Gronstedt H; Seiger A; Vikstrom S; Wimo A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2021;83(3):1149-1159
A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project
Wimo A; Belger M; Bon J; Jessen F; Dumas A; Kramberger MG; Jamilis L; Johansson G; Rodrigo Salas A; Gomez OR; Sannemann L; Stoekenbroek M; Gurruchaga Telleria M; Valero S; Vermunt L; Waterink L; Winblad B; Jelle Visser P; Zwan M; Boada M
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2021;22(9):1939-1945.e3
Response and Adherence of Nursing Home Residents to a Nutrition/ Exercise Intervention
Karlsson ES; Gronstedt HK; Faxen-Irving G; Franzen E; Luiking YC; Seiger A; Vikstrom S; Wimo A; Cederholm TE; Bostrom A-M
Article: JOURNAL OF ALZHEIMERS DISEASE. 2021;82(4):1461-1466
Effect of a Multidomain Lifestyle Intervention on Estimated Dementia Risk
Solomon A; Handels R; Wimo A; Antikainen R; Laatikainen T; Levalahti E; Peltonen M; Soininen H; Strandberg T; Tuomilehto J; Kivipelto M; Ngandu T
Article: BMJ OPEN. 2021;11(6):e049762
Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial
Eggink E; Hafdi M; Hoevenaar-Blom MP; Song M; Andrieu S; Barnes LE; Birck C; Brooks RL; Coley N; Ford E; Georges J; van der Groep A; van Gool WA; Handels R; Hou H; Li D; Liu H; Lyu J; van Marwijk H; van der Meijden M; Niu Y; Sadhwani S; Wang W; Wang Y; Wimo A; Ye X; Yu Y; Zeng Q; Zhang W; Wang W; Brayne C; van Charante EPM; Richard E
Article: NEUROLOGY. 2021;96(17):E2220-E2230
Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
Xu H; Garcia-Ptacek S; Jonsson L; Wimo A; Nordstrom P; Eriksdotter M
Article: QUALITY OF LIFE RESEARCH. 2021;30(2):577-588
A validation study of the CarerQol instrument in informal caregivers of people with dementia from eight European countries
Voormolen DC; van Exel J; Brouwer W; Skoldunger A; Goncalves-Pereira M; Irving K; Bieber A; Selbaek G; Woods B; Zanetti O; Verhey F; Wimo A; Handels RLH
Article: FRONTIERS IN NEUROLOGY. 2021;12:733878
Design and Development of a Mobile Health (mHealth) Platform for Dementia Prevention in the Prevention of Dementia by Mobile Phone Applications (PRODEMOS) Project
Hafdi M; Eggink E; Hoevenaar-Blom MP; Witvliet MP; Andrieu S; Barnes L; Brayne C; Brooks R; Coley N; Georges J; van der Groep A; van Marwijk H; van der Meijden M; Song L; Song M; Wang Y; Wang W; Wang W; Wimo A; Ye X; Moll van Charante EP; Richard E
Article: ALZHEIMER'S AND DEMENTIA: DIAGNOSIS, ASSESSMENT AND DISEASE MONITORING. 2021;13(1):e12130
General practitioners' attitude toward early and pre-dementia diagnosis of AD in five European countries-A MOPEAD project survey
Sannemann L; Mueller T; Waterink L; Zwan M; Wimo A; Stomrud E; Pino S; Arrufat J; Rodriguez-Gomez O; Benaque A; Bon J; Ferreira D; Johansson G; Dron A; Dumas A; Georges J; Kramberger MG; Visser PJ; Winblad B; Campo L; Boada M; Jessen F
Journal article: ALZHEIMER'S AND DEMENTIA: TRANSLATIONAL RESEARCH AND CLINICAL INTERVENTIONS. 2021;7(1):e12200
Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019
Nichols E; Abd-Allah F; Abdoli A; Abosetugn AE; Abrha WA; Abualhasan A; Abu-Gharbieh E; Akinyemi RO; Alahdab F; Alanezi FM-H; Alipour V; Ansari I; Arabloo J; Ashraf-Ganjouei A; Avan A; Ayano G; Babar Z-U; Baig AA; Banach M; Barboza MA; Barker-Collo SL; Baune BT; Bhagavathula AS; Bhattacharyya K; Bijani A; Biondi A; Birhan TA; Biswas A; Bolla SR; Boloor A; Brayne C; Brenner H; Burkart K; Burns RA; Nagaraja SB; Carvalho F; Castro-de-Araujo LFS; Catala-Lopez F; Cerin E; Cernigliaro A; Cherbuin N-L; Choi J-YJ; Chu D-T; Dagnew B; Dai X; Dandona L; Dandona R; Diaz D; Forooshani ZSD; Douiri A; Duncan BB; Edvardsson D; El-Jaafary SI; Eskandari K; Eskandarieh S; Feigin VL; Fereshtehnejad S-M; Fernandes E; Ferrara P; Filip I; Fischer F; Gaidhane S; Gebregzabiher KZ; Ghashghaee A; Gholamian A; Gnedovskaya EV; Golechha M; Gupta R; Hachinski V; Hamidi S; Hankey GJ; Maria Haro J; Hassan A; Hay SI; Heidari G; Heidari-Soureshjani R; Househ M; Hussain R; Hwang B-F; Ilic IM; Ilic MD; Irvani SSN; Iso H; Iwagami M; Jha RP; Kalani R; Kandel H; Karch A; Kasa AS; Kengne AP; Kim Y-E; Kim YJ; Kisa S; Kisa A; Kivimaki M; Komaki H; Koyanagi A; Kukull WA; Kumar GA; Kumar M; Landires I; Leonardi M; Lim SS; Liu X; Logroscino G; Lopez AD; Lorkowski S; Loy CT; Amin HIM; Manafi N; Manjunatha N; Mehndiratta MM; Menezes RG; Meretoja A; Merkin A; Metekiya WM; Misganaw AT; Mohajer B; Ibrahim NM; Mohammad Y; Mohapatra A; Mohebi F; Mokdad AH; Mondello S; Mossie TB; Mulugeta A; Nagel G; Naveed M; Nayak VC; Kandel SN; Son HN; Huong LTN; Nunez-Samudio V; Ogbo FA; Olagunju AT; Orru H; Ostojic SM; Ostroff SM; Otstavnov N; Otstavnov SS; Owolabi MO; Pathak M; Toroudi HP; Peterson CB; Hai QP; Phillips MR; Piradov MA; Pottoo FH; Prada SI; Pribadi DRA; Radfar A; Raggi A; Rahim F; Ram P; Rana J; Rashedi V; Rawaf S; Rawaf DL; Reinig N; Rezaei N; Robinson SR; Romoli M; Sachdev PS; Sahathevan R; Sahebkar A; Sahraian MA; Sattin D; Saylan M; Sayyah M; Schiavolin S; Schmidt MI; Shahid I; Shaikh MA; Shigematsu M; Shin JI; Shiri R; Siddiqi TJ; Silva JP; Singh JA; Soheili A; Spurlock EE; Szoeke CEI; Tabares-Seisdedos R; Taddele BW; Thakur B; ThekkePurakkal AS; Tovani-Palone MR; Tran BX; Travillian RS; Tripathi M; Tsegaye GW; Usman MS; Vacante M; Zuleika Velazquez D; Venketasubramanian N; Vidale S; Vlassov V; Wang Y-P; Wei J; Weiss J; Weldemariam AH; Wimo A; Wu C; Yadollahpour A; Yamagishi K; Yeshitila YG; Yonemoto N; Zadey S; Zhang Z-J; Murray CJL; Vos T
Article: THE JOURNAL OF FRAILTY & AGING. 2021;10(1):17-21
DO MALNUTRITION, SARCOPENIA AND FRAILTY OVERLAP IN NURSING-HOME RESIDENTS?
Faxen-Irving G; Luiking Y; Gronstedt H; Franzen E; Seiger A; Vikstrom S; Wimo A; Bostrom A-M; Cederholm T
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S6)
The IMI‐EU H2020 project MOPEAD: Outcome of different screening methods to identify MCI/early AD
Winblad B; Jessen F; Kramberger MG; Visser PJ; Rodrigo A; Jamilis L; Rodriguez‐Gomez O; Sannemann L; Zwan MD; Bon J; Johansson G; Nelvig A; Haglund A; Jelic V; Campo L; Wimo A; Boada M; Consortium M
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S6)
Long‐term treatment with cholinesterase inhibitors in Alzheimer's disease is associated with modest but persisting benefits on cognition and reduced mortality
Eriksdotter M; Xu H; Jönsson L; Wimo A; Nordström P; Garcia‐Ptacek S
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S10)
Prevention of dementia using mobile phone applications (PRODEMOS): A randomized controlled trial in progress
Eggink E; van Charante EPM; Hoevenaar‐Blom MP; Andrieu S; Hafdi M; Coley N; Sadhwani S; Wimo A; Barnes L; Handels R; Kivipelto M; Song M; Georges J; van Der Groep B; van der Meijden M; Wang Y; Wang W; van Gool WA; van Marwijk H; Brayne C; Richard E
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S6)
General practitioners’ opinion on early and pre‐dementia diagnosis of AD: A MOPEAD project survey in five European countries
Sannemann L; Müller T; Waterink L; Zwan MD; Wimo A; Stomrud E; Pino S; Espinosa JA; Rodriguez‐Gomez O; Benaque A; Bon J; Dron A; Ferreira D; Johansson G; Dumas A; Georges J; Kramberger MG; Visser PJ; Winblad B; Campo L; Boada M; Jessen F; Consortium TM
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S6)
Pre‐screening models for patient engagement: The MOPEAD project
Boada M; Winblad B; Jessen F; Visser PJ; Kramberger MG; Rodrigo A; Simó R; Rodriguez O; Sannemann L; Bon J; Zwan MD; Alegret M; Sanabria A; Rosende‐Roca M; Krivec D; Jamilis L; Trigueros P; Kivipelto M; Johansson G; Wimo A; Valero S; Shering C; Glaysher B; Tarraga L; Dumas A; Georges J; Campo L
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S7)
Informal care time in dementia by cognitive, functional and behavioral disease severity from eight longitudinal cohorts across multiple countries
Handels R; Jönsson L; Green C; Winblad B; Wimo A; Actifcare ID
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S8)
A cost‐consequence analysis of early detection of AD in the MOPEAD project — A project within the EU research agenda IMI‐2
Wimo A; Belger M; Bon J; Vugt M; Jessen F; Kramberger MG; Jamilis L; Johansson G; Rodrigo A; Rodriguez‐Gomez O; Sannemann L; Stoekenbroek M; Stomrud E; Gurrutxaga M; Valero S; Vermunt L; Waterink L; Winblad B; Zwan MD; Boada M; MOPEAD
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S10)
Time to invest in nonpharmacological interventions for behaviours and psychological symptoms associated with dementia
Burley CV; Livingston G; Knapp MRJ; Wimo A; Norman R; Brodaty H
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2020;21(11):1609-1616.e1
Profiles of Met and Unmet Needs in People with Dementia According to Caregivers' Perspective: Results from a European Multicenter Study
Janssen N; Handels RL; Kohler S; Goncalves-Pereira M; Marques MJ; Irving K; Hopper L; Bieber A; Orrell M; Selbaek G; Michelet M; Wimo A; Zanetti O; Portolani DM; Woods B; Jelley H; Evers SMAA; Verhey FRJ
Article: THE LANCET. HEALTHY LONGEVITY. 2020;1(1):e2-e3
The art of simulation
Wimo A; Handels R; Jonsson L
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2020;21(9):1229-1237
Effect of Sit-to-Stand Exercises Combined With Protein-Rich Oral Supplementation in Older Persons: The Older Person's Exercise and Nutrition Study
Gronstedt H; Vikstrom S; Cederholm T; Franzen E; Luiking YC; Seiger A; Wimo A; Faxen-Irving G; Bostrom A-M
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2020;311:46-51
Health economic evaluation of implantable cardioverter defibrillators in hypertrophic cardiomyopathy in adults
Magnusson P; Wimo A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2020;75(3):891-902
Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions
Wimo A; Handels R; Winblad B; Black CM; Johansson G; Salomonsson S; Eriksdotter M; Khandker RK
Article: ALZHEIMERS & DEMENTIA. 2020;16(5):789-796
Controlling for selective dropout in longitudinal dementia data: Application to the SveDem registry
Handels R; Jonsson L; Garcia-Ptacek S; Eriksdotter M; Wimo A
Article: JOURNAL OF ADVANCED NURSING. 2020;76(3):856-866
Well-being and thriving in sheltered housing versus ageing in place: Results from the U-age sheltered housing study.
Corneliusson L; Sköldunger A; Sjögren K; Lövheim H; Lindkvist M; Wimo A; Winblad B; Sandman P-O; Edvardsson D
Article: INTERNATIONAL PSYCHOGERIATRICS. 2020;32(2):267-277
Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS
Reed C; Belger M; Scott Andrews J; Tockhorn-Heidenreich A; Jones RW; Wimo A; Dodel R; Haro JM
Article: AGING & MENTAL HEALTH. 2020;24(2):272-279
Do caregiver profiles predict the use of dementia care services? Findings from the Actifcare study
Kerpershoek L; Woods B; Wolfs C; Verhey F; Jelley H; Bieber A; Stephan A; Michelet M; Selbaek G; Handels R; Wimo A; Hopper L; Irving K; Marques MJ; Goncalves-Pereira M; Portolani E; Zanetti O; de Vugt M; Meyer G; Broda A; Bartoszek G; Orrell M; Skoldunger A; Sjolund B-M; Engedal K; Rosvik J; Eriksen S; Joyce R; Balsinha MC; Machado A
Article: AGING & MENTAL HEALTH. 2020;24(1):162-170
A comparison of self and proxy quality of life ratings for people with dementia and their carers: a European prospective cohort study
O'Shea E; Hopper L; Marques M; Goncalves-Pereira M; Woods B; Jelley H; Verhey F; Kerpershoek L; Wolfs C; de Vugt M; Stephan A; Bieber A; Meyer G; Wimo A; Michelet M; Selbaek G; Portolani E; Zanetti O; Irving K
Article: QUALITY OF LIFE RESEARCH. 2020;29(1):237-251
A validation study of the ICECAP-O in informal carers of people with dementia from eight European Countries
Perry-Duxbury M; van Exel J; Brouwer W; Skoldunger A; Goncalves-Pereira M; Irving K; Meyer G; Selbaek G; Woods B; Zanetti O; Verhey F; Wimo A; Handels RLH
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2020;35(1):45-52
Is there equity in initial access to formal dementia care in Europe? The Andersen Model applied to the Actifcare cohort
Kerpershoek L; de Vugt M; Wolfs C; Orrell M; Woods B; Jelley H; Meyer G; Bieber A; Stephan A; Selbaek G; Michelet M; Wimo A; Handels R; Irving K; Hopper L; Goncalves-Pereira M; Balsinha C; Zanetti O; Portolani D; Verhey F
Article: ALZHEIMERS & DEMENTIA. 2019;15(10):1309-1321
Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework
Green C; Handels R; Gustavsson A; Wimo A; Winblad B; Skoldunger A; Jonsson L
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2019;20(8):988-994.e2
Using an Integrated Clinical and Functional Assessment Tool to Describe the Use of Social and Medical Care in an Urban Community-Dwelling Swedish Older Population
Santoni G; Meinow B; Wimo A; Marengoni A; Fratiglioni L; Calderon-Larranaga A
Article: BMJ OPEN. 2019;9(7):e026733
Classification tree model of the personal economic burden of dementia care by related factors of both people with dementia and caregivers in Japan: a cross-sectional online survey
Nakabe T; Sasaki N; Uematsu H; Kunisawa S; Wimo A; Imanaka Y
Journal article: ALZHEIMERS & DEMENTIA. 2019;15(7S_Part_4):p245
P1‐033: ASSOCIATION WITH REDUCED MORTALITY USING CHOLINESTERASE INHIBITORS IN PATIENTS WITH DEMENTIA: DATA FROM SVEDEM, THE SWEDISH DEMENTIA REGISTRY
Xu H; Garcia-Ptacek S; Jonsson L; Wimo A; Nordström P; Eriksdotter M
Journal article: ALZHEIMERS & DEMENTIA. 2019;15(7S_Part_31):p1636
O5‐08‐04: A NEW OPEN‐SOURCE MODELING FRAMEWORK TO ASSESS COST EFFECTIVENESS OF EARLY INTERVENTION IN ALZHEIMER'S DISEASE
Green C; Handels R; Gustavsson A; Wimo A; Skoldunger A; Winblad B; Jonsson L
Journal article: ALZHEIMERS & DEMENTIA. 2019;15(7S_Part_31):p1637
O5‐08‐05: STRUCTURAL UNCERTAINTY AND CROSS‐VALIDATION OF DECISION MODELS IN THE AD SETTING: ANSWERING QUESTIONS FROM POLICY MAKERS ON THE RELIABILITY OF HEALTH‐ECONOMIC MODELS
Handels R; Jönsson L; Green C; Eriksdotter M; Qiu C; Winblad B; Wimo A
Article: HEALTH & SOCIAL CARE IN THE COMMUNITY. 2019;27(4):e313-e322
Residing in sheltered housing versus ageing in place - Population characteristics, health status and social participation
Corneliusson L; Skoldunger A; Sjogren K; Lovheim H; Wimo A; Winblad B; Sandman P-O; Edvardsson D
Journal article: ALZHEIMERS & DEMENTIA. 2019;15(7S_Part_9):p501
P1‐588: QUANTIFYING AND DESCRIBING THE NATURAL HISTORY OF AD AND ECONOMIC EFFECTS OF HYPOTHETICAL INTERVENTIONS
Wimo A; Black CM; Chekani F; Eriksdotter M; Johansson G; Handels R; Salomonsson S; Winblad B; Khandker RK
Article: ACTA MEDICA PORTUGUESA. 2019;32(5):355-367
Needs for Care and Service Use in Dementia: Baseline Assessment of Portuguese Participants in the Actifcare Cohort Study
Goncalves-Pereira M; Marques MJ; Balsinha C; Fernandes A; Machado AS; Verdelho A; Barahona-Correa B; Barrios H; Guimaraes J; Grave J; Alves L; de Almeida MC; Reis T; Orrell M; Woods B; De Vugt M; Verhey F; Wolfs C; Handels R; Kerpershoek L; Meyer G; Stephan A; Bieber A; Broda A; Bartoszek G; Jelley H; Wimo A; Skoldunger A; Sjolund B-M; Engedal K; Selbaek G; Michalet M; Rosvik J; Eriksen S; Irving K; Hopper L; Joyce R; Zanetti O; Portolani E
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2019;20(3):343-355
Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementia
Belger M; Haro JM; Reed C; Happich M; Argimon JM; Bruno G; Dodel R; Jones RW; Vellas B; Wimo A
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2019;34(2):337-351
The use of direct care in nursing home residents: A longitudinal cohort study over 3 years
Vossius C; Selbaek G; Benth JS; Wimo A; Bergh S
Article: AGING & MENTAL HEALTH. 2019;23(1):53-59
Challenges and recommendations for the health-economic evaluation of primary prevention programmes for dementia
Handels R; Wimo A
Article: PLOS ONE. 2019;14(8):e0219568
Cost analysis of day care centres in Norway
Vossius C; Selbaek G; Benth JS; Wimo A; Engedal K; Kirkevold O; Rokstad AMM
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2019;34(1):130-136
Resource use and its association to cognitive impairment, ADL functions, and behavior in residents of Swedish nursing homes: Results from the U-Age program (SWENIS study)
Skoldunger A; Wimo A; Sjogren K; Bjork S; Backman A; Sandman P-O; Edvardsson D
Article: GERONTOLOGY AND GERIATRIC MEDICINE. 2019;5:2333721419859687
Prevalence and Incidence of Atrial Fibrillation and Other Arrhythmias in the General Older Population: Findings From the Swedish National Study on Aging and Care
Lindberg T; Wimo A; Elmstahl S; Qiu C; Bohman DM; Berglund JS
Article: JOURNAL OF ADVANCED NURSING. 2018;74(12):2820-2830
Exploring resident thriving in relation to the nursing home environment: A cross-sectional study
Bjork S; Lindkvist M; Lovheim H; Bergland A; Wimo A; Edvardsson D
Article: JOURNAL OF ALZHEIMERS DISEASE. 2018;66(3):1165-1174
Impact of Untimely Access to Formal Care on Costs and Quality of Life in Community Dwelling People with Dementia
Janssen N; Handels RL; Skoldunger A; Woods B; Jelley H; Edwards RT; Orrell M; Selbaek G; Rosvik J; Goncalves-Pereira M; Marques MJ; Zanetti O; Portolani E; Irving K; Hopper L; Meyer G; Bieber A; Stephan A; Kerpershoek L; Wolfs CAG; de Vugt ME; Verhey FRJ; Wimo A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2018;66(3):1027-1040
Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study
Handels RLH; Skoldunger A; Bieber A; Edwards RT; Goncalves-Pereire M; Hopper L; Irving K; Jelley H; Kerpershoek L; Marques MJ; Meyer G; Michelet M; Portolani E; Rosvik J; Selbaek G; Stephan A; de Vugt M; Wolfs C; Woods B; Zanetti O; Verhey F; Wimo A
Journal article: INNOVATION IN AGING. 2018;2(suppl_1):421
COGNITIVE IMPAIRMENT AND ITS ASSOCIATION TO RESOURSE USE AND COSTS IN RESIDENTS IN SWEDISH NURSING HOMES
Sköldunger A; Wimo A; Sjögren K; Björk S; Backman A; Sandman PO
Journal article: INNOVATION IN AGING. 2018;2(suppl_1):308
PREDICTORS OF PHYSICAL AND LEISURE ACTIVITIES IN RESIDENTIAL AGED CARE FACILITIES IN SWEDEN: U-AGE SWENIS STUDY
Rahman M; Sköldunger A; Sjögren K; Lövheim H; Wimo A; Winblad B; Sandman P; Edvardsson D
Journal article: INNOVATION IN AGING. 2018;2(suppl_1):507
PREVALENCE OF SUBJECTIVE COGNITIVE DECLINE (SCD) AND THE ASSOCIATION OF MOVING TO SHELTERED HOUSING
Sköldunger A; Wimo A; Sjögren K; Sandman P; Balash L; Winblad B; Edvardsson D
Article: JOURNAL OF PARKINSONS DISEASE. 2018;8(4):553-561
No Significant Difference in Cognitive Decline and Mortality between Parkinson's Disease Dementia and Dementia with Lewy Bodies: Naturalistic Longitudinal Data from the Swedish Dementia Registry
Fereshtehnejad S-M; Lokk J; Wimo A; Eriksdotter M
Journal article: CLINICAL NUTRITION. 2018;37:s59-s60
Relationships between nutritional status, sarcopenia and frailty in nursing-home residents
Faxen-Irving G; Cederholm T; Grönstedt H; Franzen E; Seiger Å; Wikström S; Wimo A; Boström A-M
Article: AGING & MENTAL HEALTH. 2018;22(7):897-902
Needs and quality of life of people with middle-stage dementia and their family carers from the European Actifcare study. When informal care alone may not suffice
Kerpershoek L; de Vugt M; Wolfs C; Woods B; Jelley H; Orrell M; Stephan A; Bieber A; Meyer G; Selbaek G; Handels R; Wimo A; Hopper L; Irving K; Marques M; Goncalves-Pereira M; Portolani E; Zanetti O; Verhey F
Journal article: ALZHEIMERS & DEMENTIA. 2018;14(7S_Part_22):p1197-p1198
P3‐304: MODELS OF PATIENT ENGAGEMENT IN ALZHEIMER'S DISEASE (MOPEAD): A EUROPEAN MULTINATIONAL PROJECT TO DEVELOP AND TEST INNOVATIVE PATIENT ENGAGEMENT STRATEGIES
Rodriguez-Gomez O; Campo L; Datto C; Hundemer HP; Winblad B; Johansson G; Wimo A; Jessen F; Sannemann L; Visser PJ; Zwan MD; Kramberger MG; Simó R; Pérez-Garro I; Rodrigo A; Dumas A; Georges J; Krivec D; Maguire P; Semancik K; Glaysher B; Boada M
Journal article: ALZHEIMERS & DEMENTIA. 2018;14(7S_Part_31):p1663
O5‐07‐04: DEMENTIA INFORMAL CARE COSTS IN THE SLOVENIAN CENTRE FOR COGNITIVE IMPAIRMENTS
Zupanic E; Wimo A; Winblad B; Petek D; Petek B; Kramberger MG
Article: ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE. 2018;51(5):530-536
Access to community care for people with dementia and their informal carers Case vignettes for a European comparison of structures and common pathways to formal care
Bieber A; Stephan A; Verbeek H; Verhey F; Kerpershoek L; Wolfs C; de Vugt M; Woods RT; Rosvik J; Selbaek G; Sjolund BM; Wimo A; Hopper L; Irving K; Marques MJ; Goncalves-Pereira M; Portolani E; Zanetti O; Meyer G
Article: ALZHEIMERS & DEMENTIA. 2018;14(7):895-901
Apolipoprotein E genotypes and longevity across dementia disorders
Skillback T; Lautner R; Mattsson N; Schott JM; Skoog I; Nagga K; Kilander L; Wimo A; Winblad B; Eriksdotter M; Blennow K; Zetterberg H
Article: JOURNAL OF ALZHEIMERS DISEASE. 2018;64(s1):S41-S46
The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View
Wimo A
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2018;33(9):1243-1252
The personal cost of dementia care in Japan: A comparative analysis of residence types
Nakabe T; Sasaki N; Uematsu H; Kunisawa S; Wimo A; Imanaka Y
Article: BMC GERIATRICS. 2018;18(1):138
A study protocol of Older Person's Exercise and Nutrition Study (OPEN) - a sit-to-stand activity combined with oral protein supplement - effects on physical function and independence: a cluster randomized clinical trial
Gronstedt H; Vikstrom S; Cederholm T; Franzen E; Seiger A; Wimo A; Faxen-Irving G; Bostrom A-M
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2018;33(1):e49-e57
Thriving in relation to cognitive impairment and neuropsychiatric symptoms in Swedish nursing home residents
Bjork S; Lovheim H; Lindkvist M; Wimo A; Edvardsson D
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2018;19(1):95.e1-95.e10
Costs of Care of Agitation Associated With Dementia in 8 European Countries: Results From the RightTimePlaceCare Study
Costa N; Wuebker A; De Mauleon A; Zwakhalen SMG; Challis D; Leino-Kilpi H; Hallberg IR; Stephan A; Zabalegui A; Saks K; Molinier L; Wimo A; Vellas B; Sauerland D; Binot I; Soto ME
Article: GERONTOLOGY AND GERIATRIC MEDICINE. 2018;4:2333721418786565
Relationships Between Frequency of Moderate Physical Activity and Longevity: An 11-Year Follow-up Study
Rennemark M; Jogreus A; Elmstahl S; Weimer A-K; Wimo A; Sanmartin-Berglund J
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;60(4):1477-1487
Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia
Handels RLH; Wimo A; Dodel R; Kramberger MG; Visser PJ; Luis Molinuevo J; Verhey FRJ; Winblad B
Article: NEUROBIOLOGY OF AGING. 2017;59:1-9
CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients
Skillback T; Delsing L; Synnergren J; Mattsson N; Janelidze S; Nagga K; Kilander L; Hicks R; Wimo A; Winblad B; Hansson O; Blennow K; Eriksdotter M; Zetterberg H
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2017;18(8):979-986
Costs of dementia in the Czech Republic
Holmerova I; Hort J; Rusina R; Wimo A; Steffl M
Article: JOURNAL OF ADVANCED NURSING. 2017;73(8):1884-1895
Residents' engagement in everyday activities and its association with thriving in nursing homes
Bjork S; Lindkvist M; Wimo A; Juthberg C; Bergland A; Edvardsson D
Journal article: INNOVATION IN AGING. 2017;1(suppl_1):593
THE CONTENT AND FOCUS OF THE SWEDISH NATIONAL INVENTORY OF HEALTH AND CARE (SWENIS)
Backman A; Bjork S; Lövheim H; Sjögren K; Skoldunger A; Wimo A; Sandman P; Edvardsson D
Journal article: ALZHEIMERS & DEMENTIA. 2017;13(7S_Part_17):p860
[P2–560]: CHALLENGES AND RECOMMENDATIONS FOR THE HEALTH‐ECONOMIC EVALUATION OF PRIMARY PREVENTION PROGRAMS FOR DEMENTIA
Handels R; Wimo A
Journal article: INNOVATION IN AGING. 2017;1(suppl_1):255
A PERSON-CENTERED APPROACH TO PREDICTING THE USE OF MEDICAL CARE AND SOCIAL SERVICES IN OLDER ADULTS
Santoni G; Calderón-Larrañaga A; Marengoni A; Wimo A; Fratiglioni L
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;57(3):797-812
What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study
Reed C; Happich M; Maria Argimon J; Maria Haro J; Wimo A; Bruno G; Dodel R; Jones RW; Vellas B; Belger M
Article: ALZHEIMERS & DEMENTIA. 2017;13(3):312-321
Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease
Gustavsson A; Green C; Jones RW; Foerstl H; Simsek D; de Vulpillieres FDR; Luthman S; Adlard N; Bhattacharyya S; Wimo A
Article: BMC GERIATRICS. 2017;17(1):61
Systematic pain assessment in nursing homes: a cluster-randomized trial using mixed-methods approach
Mamhidir A-G; Sjoelund B-M; Flaeckman B; Wimo A; Skoeldunger A; Engstroem M
Article: HEALTH AND QUALITY OF LIFE OUTCOMES. 2017;15(1):16
How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease?
Reed C; Barrett A; Lebrec J; Dodel R; Jones RW; Vellas B; Wimo A; Maria Argimon J; Bruno G; Maria Haro J
Article: AGING & MENTAL HEALTH. 2017;21(1):49-57
Caregiver profiles in dementia related to quality of life, depression and perseverance time in the European Actifcare study: the importance of social health
Janssen EPCJ; de Vugt M; Kohler S; Wolfs C; Kerpershoek L; Handels RLH; Orrell M; Woods B; Jelley H; Stephan A; Bieber A; Meyer G; Engedal K; Selbaek G; Wimo A; Irving K; Hopper L; Marques M; Goncalves-Pereira M; Portolani E; Zanetti O; Verhey FR
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA. 2017;7(1):87-100
Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes.
Jones RW; Lebrec J; Kahle-Wrobleski K; Dell'Agnello G; Bruno G; Vellas B; Argimon JM; Dodel R; Haro JM; Wimo A; Reed C
Article: ALZHEIMERS & DEMENTIA. 2017;13(1):1-7
The worldwide costs of dementia 2015 and comparisons with 2010
Wimo A; Guerchet M; Ali G-C; Wu Y-T; Prina AM; Winblad B; Jonsson L; Liu Z; Prince M
Article: BULLETIN OF THE WORLD HEALTH ORGANIZATION. 2017;95(1):18-26
The economic burden of dementia in China, 1990-2030: implications for health policy
Xu J; Wang J; Wimo A; Fratiglioni L; Qiu C
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2017;21(1):17-24
FORMAL AND INFORMAL CARE OF COMMUNITY-LIVING OLDER PEOPLE: A POPULATION-BASED STUDY FROM THE SWEDISH NATIONAL STUDY ON AGING AND CARE
Wimo A; Elmstahl S; Fratiglioni L; Sjlolund B-M; Skoldunger A; Fagerstrom C; Berglund J; Lagergren M
Article: JOURNAL OF AGING AND HEALTH. 2016;28(8):1448-1464
Cost of Dementia and Its Correlation With Dependence
Akerborg O; Lang A; Wimo A; Skoldunger A; Fratiglioni L; Gaudig M; Rosenlund M
Article: ALZHEIMERS RESEARCH & THERAPY. 2016;8(1):59
The societal costs of dementia in Sweden 2012-relevance and methodological challenges in valuing informal care
Wimo A; Jonsson L; Fratiglioni L; Sandman PO; Gustavsson A; Skoldunger A; Johansson L
Journal article: NORDIC JOURNAL OF NURSING RESEARCH. 2016;36(3):168-174
The Umeå ageing and health research programme (U-Age): Exploring person-centred care and health-promoting living conditions for an ageing population
Edvardsson D; Backman A; Bergland Å; Björk S; Bölenius K; Kirkevold M; Lindkvist M; Lood Q; Lämås K; Lövheim H; Sandman P-O; Sjögren K; Sköldunger A; Wimo A; Winblad B
Article: BMC HEALTH SERVICES RESEARCH. 2016;16(1):423
Access to timely formal dementia care in Europe: protocol of the Actifcare (ACcess to Timely Formal Care) study
Kerpershoek L; de Vugt M; Wolfs C; Jelley H; Orrel M; Woods B; Stephan A; Bieber A; Meyer G; Engedal K; Selbaek G; Handels R; Wimo A; Hopper L; Irving K; Marques M; Goncalves-Pereira M; Portolani E; Zanetti O; Verhey F
Article: BMC GERIATRICS. 2016;16(1):154
Exploring the prevalence and variance of cognitive impairment, pain, neuropsychiatric symptoms and ADL dependency among persons living in nursing homes; a cross-sectional study
Bjork S; Juthberg C; Lindkvist M; Wimo A; Sandman P-O; Winblad B; Edvardsson D
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2016;16:83
How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study
Belger M; Haro JM; Reed C; Happich M; Kahle-Wrobleski K; Argimon JM; Bruno G; Dodel R; Jones RW; Vellas B; Wimo A
Article: BMC PSYCHIATRY. 2016;16:137
The economic burden of mental disorders in China, 2005-2013: implications for health policy
Xu J; Wang J; Wimo A; Qiu C
Article: LANCET NEUROLOGY. 2016;15(5):455-532
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad B; Amouyel P; Andrieu S; Ballard C; Brayne C; Brodaty H; Cedazo-Minguez A; Dubois B; Edvardsson D; Feldman H; Fratiglioni L; Frisoni GB; Gauthier S; Georges J; Graff C; Iqbal K; Jessen F; Johansson G; Jonsson L; Kivipelto M; Knapp M; Mangialasche F; Melis R; Nordberg A; Rikkert MO; Qiu C; Sakmar TP; Scheltens P; Schneider LS; Sperling R; Tjernberg LO; Waldemar G; Wimo A; Zetterberg H
Article: BMC NEUROLOGY. 2016;16:28
The impact of dementia on drug costs in older people: results from the SNAC study
Skoldunger A; Fastbom J; Wimo A; Fratiglioni L; Johnell K
Article: AGING CLINICAL AND EXPERIMENTAL RESEARCH. 2016;28(1):147-158
Horizontal and vertical targeting: a population-based comparison of public eldercare services in urban and rural areas of Sweden
Lagergren M; Fagerstrom C; Sjolund B-M; Berglund J; Fratiglioni L; Nordell E; von Strauss E; Wimo A; Elmstahl S
Article: INTERNATIONAL PSYCHOGERIATRICS. 2016;28(2):247-259
Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease
Reed C; Belger M; Vellas B; Andrews JS; Argimon JM; Bruno G; Dodel R; Jones RW; Wimo A; Haro JM
Article: JOURNAL OF ALZHEIMERS DISEASE. 2016;50(2):387-396
Cohort Effects in the Prevalence and Survival of People with Dementia in a Rural Area in Northern Sweden
Wimo A; Sjolund B-M; Skoldunger A; Qiu C; Klarin I; Nordberg G; von Strauss E
Article: ALZHEIMERS & DEMENTIA. 2015;11(12):1470-1479
Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem
Rosen C; Farahmand B; Skillback T; Nagga K; Mattsson N; Kilander L; Religa D; Wimo A; Blennow K; Winblad B; Zetterberg H; Eriksdotter M
Article: BRAIN. 2015;138(Pt 9):2716-2731
Cerebrospinal fluid tau and amyloid-β_1-42 in patients with dementia
Skillback T; Farahmand BY; Rosen C; Mattsson N; Nagga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
Article: DRUGS & AGING. 2015;32(8):671-678
Impact of Inappropriate Drug Use on Hospitalizations, Mortality, and Costs in Older Persons and Persons with Dementia: Findings from the SNAC Study
Skoldunger A; Fastbom J; Wimo A; Fratiglioni L; Johnell K
Article: ALZHEIMERS & DEMENTIA. 2015;11(8):896-905
Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment
Handels RLH; Joore MA; Tran-Duy A; Wimo A; Wolfs CAG; Verhey FRJ; Severens JL
Article: ALZHEIMERS & DEMENTIA. 2015;11(8):933-945
Determinants of societal costs in Alzheimer's disease: GERAS study baseline results
Dodel R; Belger M; Reed C; Wimo A; Jones RW; Happich M; Argimon JM; Bruno G; Vellas B; Maria Haro J
Journal article: ALZHEIMERS & DEMENTIA. 2015;11(7S_Part_3):p119
F1‐04‐01: Care interventions practices through research on policy
Wimo A
Article: ALZHEIMERS & DEMENTIA. 2015;11(4):455-461
Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease
Bradley P; Akehurst R; Ballard C; Banerjee S; Blennow K; Bremner J; Broich K; Cummings J; Dening K; Dubois B; Klipper W; Leibman C; Mantua V; Luis Molinuevo J; Morgan S; Muscolo LAA; Nicolas F; Pani L; Robinson L; Siviero P; van Dam J; Van Emelen J; Wimo A; Wortmann M; Goh L
Journal article: CLINICAL NURSING STUDIES. 2015;3(2)
Comparing estimated cost per patient for dementia care: Two municipalities and Swedish national population data
Jedenius E; Wimo A; Strömqvist J; Fastbom J; Winblad B; Winblad U; Andreasen N
Journal article: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2015;2(3):199-211
The Road Ahead To Cure And Prevent Alzheimer's Disease: Implementing Prevention into Primary Care.
Fougère B; Vellas B; Delrieu J; Sinclair AJ; Wimo A; Herman CJ; Fillit H; Gauthier S; Oustric S
Article: PLOS ONE. 2015;10(9):e0138901
Incidence of ADL Disability in Older Persons, Physical Activities as a Protective Factor and the Need for Informal and Formal Care - Results from the SNAC-N Project
Sjolund B-M; Wimo A; Engstrom M; von Strauss E
Article: PLOS ONE. 2015;10(2):e0116538
SveDem, the Swedish Dementia Registry - A Tool for Improving the Quality of Diagnostics, Treatment and Care of Dementia Patients in Clinical Practice
Religa D; Fereshtehnejad S-M; Cermakova P; Edlund A-K; Garcia-Ptacek S; Granqvist N; Hallback A; Kawe K; Farahmand B; Kilander L; Mattsson U-B; Nagga K; Nordstrom P; Wijk H; Wimo A; Winblad B; Eriksdotter M
Article: NEUROLOGY. 2014;83(21):1945-1953
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
Skillback T; Farahmand B; Bartlett JW; Rosen C; Mattsson N; Nagga K; Kilander L; Religa D; Wimo A; Winblad B; Rosengren L; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
Journal article: ALZHEIMERS & DEMENTIA. 2014;10(4S_Part_17):p608
P2‐351: TIME TRENDS IN PHYSICAL AND MENTAL FUNCTIONING COMPARING TWO POPULATIONS AGED 75+ YEARS
Sjölund B; Wimo A; Qui C; Sköldunger A; Engström M; von Strauss E
Journal article: ALZHEIMERS & DEMENTIA. 2014;10(4S_Part_23):p783
P3‐419: COHORT EFFECTS IN THE PREVALENCE OF DEMENTIA AND SURVIVAL PATTERNS IN NORDANSTIG, A RURAL COHORT PROJECT (SNAC‐N) IN NORTHERN SWEDEN
Wimo A; Sköldunger A; Sjölund B
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2014;18(7):677-684
ANALYSIS OF BURDEN IN CAREGIVERS OF PEOPLE WITH ALZHEIMER'S DISEASE USING SELF-REPORT AND SUPERVISION HOURS
Haro JM; Kahle-Wrobleski K; Bruno G; Belger M; Dell'Agnello G; Dodel R; Jones RW; Reed CC; Vellas B; Wimo A; Argimon JM
Journal article: ALZHEIMERS & DEMENTIA. 2014;10(4S_Part_15):p596
P2‐319: DRUG COSTS IN DEMENTIA CONFOUNDED BY COMORBIDITIES AND RESIDENTIAL SETTING: RESULTS FROM THE SNAC STUDY
Sköldunger A; Fastbom J; Wimo A; Sjölund B; Fratiglioni L; Johnell K
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA. 2014;4(1):51-64
Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational Study.
Reed C; Belger M; Dell'agnello G; Wimo A; Argimon JM; Bruno G; Dodel R; Haro JM; Jones RW; Vellas B
Article: ARCHIVES OF GERONTOLOGY AND GERIATRICS. 2014;58(3):370-375
Time trends in prevalence of activities of daily living (ADL) disability and survival: Comparing two populations (aged 78+years) living in a rural area in Sweden
Sjolund B-M; Wimo A; Qiu C; Engstrom M; von Strauss E
Article: AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY. 2014;22(4):381-388
The Use and Costs of Formal Care in Newly Diagnosed Dementia: A Three-Year Prospective Follow-Up Study
Vossius C; Rongve A; Testad I; Wimo A; Aarsland D
Article: AGEING & SOCIETY. 2014;34(4):700-719
Horizontal and vertical target efficiency - a comparison between users and non-users of public long-term care in Sweden
Lagergren M; Sjolund B-M; Fagerstrom C; Berglund J; Fratiglioni L; Nordell E; Wimo A; Elmstahl S
Article: SCANDINAVIAN JOURNAL OF CARING SCIENCES. 2014;28(1):97-103
Older patients referred by community nurses to emergency departments - a descriptive cross-sectional follow-up study in a Swedish context
Kihlgren A; Wimo A; Mamhidir A-G
Article: JOURNAL OF INTERNAL MEDICINE. 2014;275(3):304-316
Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria
Wimo A; Ballard C; Brayne C; Gauthier S; Handels R; Jones RW; Jonsson L; Khachaturian AS; Kramberger M
Article: HERNIA. 2014;18(6):775-780
Cost analysis of the use of small stitches when closing midline abdominal incisions
Millbourn D; Wimo A; Israelsson LA
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2013;28(10):1039-1044
Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry
Wimo A; Religa D; Spangberg K; Edlund A-K; Winblad B; Eriksdotter M
Article: JOURNAL OF ALZHEIMERS DISEASE. 2013;37(2):357-365
Natural Progression Model of Cognition and Physical Functioning among People with Mild Cognitive Impairment and Alzheimer's Disease
Handels RLH; Xu W; Rizzuto D; Caracciolo B; Wang R; Winblad B; Verhey FRJ; Severens JL; Fratiglioni L; Joore MA; Wimo A
Article: EUROPEAN HEART JOURNAL. 2013;34(33):2585-2591
The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimers disease
Nordstrom P; Religa D; Wimo A; Winblad B; Eriksdotter M
Article: ALZHEIMERS & DEMENTIA. 2013;9(4):429-435.e17
Application of Resource Utilization in Dementia (RUD) instrument in a global setting
Wimo A; Gustavsson A; Jonsson L; Winblad B; Hsu M-A; Gannon B
Article: JOURNAL OF ALZHEIMERS DISEASE. 2013;36(2):385-399
The GERAS Study: A Prospective Observational Study of Costs and Resource Use in Community Dwellers with Alzheimer's Disease in Three European Countries - Study Design and Baseline Findings
Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Maria Haro J
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2013;28(5):454-462
Costs explained by function rather than diagnosis-results from the SNAC Nordanstig elderly cohort in Sweden
Lindholm C; Gustavsson A; Jonsson L; Wimo A
Article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 2013;31(1):13-19
A Quick Test of Cognitive Speed (AQT): Usefulness in dementia evaluations in primary care
Kvitting AS; Wimo A; Johansson MM; Marcusson J
Article: CURRENT ALZHEIMER RESEARCH. 2013;10(2):207-216
Mortality and Treatment Costs have a Great Impact on the Cost-Effectiveness of Disease Modifying Treatment in Alzheimer's Disease - A Simulation Study
Skoldunger A; Johnell K; Winblad B; Wimo A
Article: ALZHEIMERS & DEMENTIA. 2013;9(1):1-11.e3
The worldwide economic impact of dementia 2010
Wimo A; Jonsson L; Bond J; Prince M; Winblad B
Article: CURRENT ALZHEIMER RESEARCH. 2012;9(10):1126-1134
Practical Lessons from Amyloid Immunotherapy Trials in Alzheimer Disease
Solomon A; Akenine U; Andreasen N; Mangialasche F; Wimo A; Jelic V; Kivipelto M; Winblad B
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2012;27(11):1112-1117
Net costs of dementia in Sweden - An Incidence Based 10 Year Simulation Study
Skoldunger A; Wimo A; Johnell K
Article: JOURNAL OF MEDICAL ECONOMICS. 2012;15(5):1019-1024
The economic impact of galantamine vs placebo: an analysis based on functional capacity in a Swedish cohort study.
Wimo A; Gaudig M; Schäuble B; Jedenius E
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2012;16(10):891-897
FEWER REFERRALS TO SWEDISH EMERGENCY DEPARTMENTS AMONG NURSING HOME PATIENTS WITH DEMENTIA, COMPREHENSIVE COGNITIVE DECLINE AND MULTICOMORBIDITY
Mamhidir A-G; Wimo A; Kihlgren A
Article: CURRENT ALZHEIMER RESEARCH. 2012;9(7):795-800
Dementia After Age 75: Survival in Different Severity Stages and Years of Life Lost
Rizzuto D; Bellocco R; Kivipelto M; Clerici F; Wimo A; Fratiglioni L
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2012;33(2-3):90-95
Dementia Diagnosis Differs in Men and Women and Depends on Age and Dementia Severity: Data from SveDem, the Swedish Dementia Quality Registry
Religa D; Spangberg K; Wimo A; Edlund A-K; Winblad B; Eriksdotter-Jonhagen M
Article: JOURNAL OF ALZHEIMERS DISEASE. 2011;26(4):735-744
Cost-Effectiveness of a Health Intervention Program with Risk Reductions for Getting Demented: Results of a Markov Model in a Swedish/Finnish Setting
Zhang Y; Kivipelto M; Solomon A; Wimo A
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2011;26(8):825-832
The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project
Wimo A; Jonsson L; Gustavsson A; McDaid D; Ersek K; Georges J; Gulacsi L; Karpati K; Kenigsberg P; Valtonen H
Article: ALZHEIMERS & DEMENTIA. 2011;7(3):318-327
Predictors of costs of care in Alzheimer's disease: A multinational sample of 1222 patients
Gustavsson A; Brinck P; Bergvall N; Kolasa K; Wimo A; Winblad B; Jonsson L
Article: INTERNATIONAL PSYCHOGERIATRICS. 2011;23(1):73-85
Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease
Bergvall N; Brinck P; Eek D; Gustavsson A; Wimo A; Winblad B; Jonsson L
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2011;26(1):56-64
Incremental patterns in the amount of informal and formal care among non-demented and demented elderly persons results from a 3-year follow-up population-based study
Wimo A; Sjolund BM; Skoldunger A; Johansson L; Nordberg G; von Strauss E
Article: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2010;58(10):1855-1862
Morbidity and Physical Functioning in Old Age: Differences According to Living Area
Sjolund B-M; Nordberg G; Wimo A; von Strauss E
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2010;14(8):685-690
The resource utilization in dementia (RUD) instrument is valid for assessing informal care time in community-living patients with dementia
Wimo A; Jonsson L; Zbrozek A
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2010;14(8):648-654
Differences in resource use and costs of dementia care between European countries: Baseline data from the ictus study
Gustavsson A; Jonsson L; Rapp T; Reynish E; Ousset PJ; Andrieu S; Cantet C; Winblad B; Vellas B; Wimo A
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2010;14(8):633-639
Costs of dementia in Hungary
Ersek K; Kovacs T; Wimo A; Karpati K; Brodszky V; Pentek M; Joensson L; Gustavsson A; Mcdaid D; Kenigsberg PA; Valtonen H; Gulacsi L
Journal article: ALZHEIMERS & DEMENTIA. 2010;6(4S_Part_11):s323
P2‐036: Changes in care patterns over time in relation to cognitive and physical functioning of non demented and demented elderly people: Results from a 3‐year follow‐up population‐based study
Sjölund B-M; Wimo A; Sköldunger A; Johansson L; Nordberg G; Von Strauss E
Journal article: ALZHEIMERS & DEMENTIA. 2010;6(4S_Part_11):s333
P2‐069: The use of drugs in demented and non‐demented people according to living situation; a comparison between rural and urban areas—results from SNAC, a population‐based multicenter study
Sköldunger AB; Sjölund B-M; Johnell K; Wimo A
Journal article: ALZHEIMERS & DEMENTIA. 2010;6(4S_Part_12):s373
P2‐202: Dementia work‐up is more costly in men than in women
Religa D; Spangberg K; Wimo A; Jonsson L; Edlund A-K; Winblad B; Eriksdotter-Jonhagen M
Journal article: AGEING INTERNATIONAL. 2010;35(2):153-165
Caregiver Time and Cost of Home Care for Alzheimer’s Disease: A Clinic-based Observational Study in Beijing, China
Wang H; Gao T; Wimo A; Yu X
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2010;25(6):622-632
Willingness-to-pay for reductions in care need: estimating the value of informal care in Alzheimer's disease
Gustavsson A; Jonsson L; McShane R; Boada M; Wimo A; Zbrozek AS
Article: CURRENT ALZHEIMER RESEARCH. 2010;7(4):358-367
Cross Sectional Observational Study on the Societal Costs of Alzheimer's Disease
Mesterton J; Wimo A; By A; Langworth S; Winblad B; Jonsson L
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2010;25(5):476-482
The cost of diagnosing dementia in a community setting
Jedenius E; Wimo A; Stromqvist J; Jonsson L; Andreasen N
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2010;14(5):358-360
IPECAD5-Fifth International Pharmaco-Economic Conference on Alzheimer's Disease
Gustavsson A; Jonsson L; Fillit H; Johansson G; Wimo A; Winblad B
Article: ALZHEIMERS & DEMENTIA. 2010;6(2):98-103
The worldwide societal costs of dementia: Estimates for 2009
Wimo A; Winblad B; Jonsson L
Article: INTERNATIONAL PSYCHOGERIATRICS. 2009;21(6):1116-1126
International price comparisons of Alzheimer's drugs: a way to close the affordability gap
Suh G-H; Wimo A; Gauthier S; O'Connor D; Ikeda M; Homma A; Dominguez J; Yang B-M
Journal article: JOURNAL OF NUTRITION HEALTH & AGING. 2009
IPECAD5 — Fifth International Pharmaco-Economic Conference on Alzheimer’s Disease
Gustavsson A; Jonsson L; Fillit H; Johansson G; Wimo A; Winblad B
Journal article: ALZHEIMERS & DEMENTIA. 2009;5(4S_Part_13):p410
P3‐228: Trends in informal care in Sweden: Is it decreasing? Cross‐sectional studies with the RUD instrument
Wimo A; Wimo A; Sjolund B; Jönsson L; Skoldunger A; Winblad B
Journal article: GERONTOLOGIE ET SOCIETE. 2009;vol. 32 / n° 128-129(1):297-318
Impact socio-économique de la maladie d'Alzheimer et des maladies apparentées en Europe
Kenigsberg P-A; Ersek K; Gulácsi L; Karpati K; Jacques A; Gustavsson A; Jönsson L; Mcdaid D; Valtonen H; Wimo A
Journal article: ALZHEIMERS & DEMENTIA. 2009;5(4S_Part_13):p407
P3‐218: Health‐economic benefits of memantine treatment: Translating symptomatic effects into cost savings
Wirth Y; Wimo A
Article: LAKARTIDNINGEN. 2009;106(18-19):1277-1282
[Prevalence study of societal costs for dementia 2000-2005. More demented people--but somewhat reduced costs per person].
Wimo A; Johansson L; Jönsson L
Journal article: LANCET NEUROLOGY. 2009;8(1):39-47
Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial.
Burns A; Bernabei R; Bullock R; Cruz Jentoft AJ; Frölich L; Hock C; Raivio M; Triau E; Vandewoude M; Wimo A; Came E; Van Baelen B; Hammond GL; van Oene JC; Schwalen S
Journal article: AKTUELLE NEUROLOGIE. 2008;35(S 01)
Die SERAD Studie: Galantamin verbessert die Kognition bei Heimpatienten mit schwerer Alzheimerdemenz
Burns A; Ibach B; Bernabei R; Bullock R; Cruz Jentoft AJ; Frölich L; Hock C; Triau E; Vandewoude M; Wimo A; Came E; van Baelen B; van Oene J; Schwalen S
Journal article: ALZHEIMERS & DEMENTIA. 2008;4(4S_Part_21):t700
P4‐106: Cognitive functioning in old age: Temporal trends in a rural area in Sweden
Sjölund B-M; Wimo A; Sköldunger A; von Strauss E
Journal article: ALZHEIMERS & DEMENTIA. 2008;4(4S_Part_20):t650-t651
P3‐441: Net costs of dementia in Sweden: An incidence‐based 10‐year simulation study
Wimo A; Sköldunger A; Sjölund B-M
Journal article: ALZHEIMERS & DEMENTIA. 2008;4(4S_Part_21):t682
P4‐049: The impact of dementia on life expectancy after age 75
Rizzuto D; Wimo A; Clerici F; Fratiglioni L
Article: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2008;63(3):275-282
Cost-effectiveness of a multidisciplinary intervention model for community-dwelling frail older people
Melis RJF; Adang E; Teerenstra S; van Eiiken MIJ; Wimo A; van Achterberg T; de Lisdonk EHV; Rikkert MGMO
Article: HANDBOOK OF CLINICAL NEUROLOGY. 2008;89:137-146
Economical aspects of dementia.
Wimo A; Winblad B
Article: WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION. 2008;31(2):209-219
Health and disability pension - An intersection of disease, psychosocial stress and gender. Long term follow up of persons with impairment of the loco motor system
Kaiser P-O; Mattsson B; Marklund S; Wimo A
Article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 2008;26(4):235-240
A Swedish programme for dementia diagnostics in primary healthcare
Jedenius E; Wimo A; Stromqvist J; Andreasen N
Journal article: ALZHEIMERS & DEMENTIA. 2007;3(3S_Part_3):s165
S1–01–01: Public health impact
Winblad B; Wimo A; Jonsson L
Journal article: ALZHEIMERS & DEMENTIA. 2007;3(3S_Part_2):s146
P‐148: The resource utilization in dementia (RUD) instrument is valid to assess informal care time in dementia
Wimo A; Jönsson L; Zbrozek AS
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2007;22(7):649-655
Health utilities in mild cognitive impairment and dementia:: a population study in Sweden
Ekman M; Berg J; Wimo A; Jonsson L; McBurney C
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2007;22(7):639-648
Time use and costs of institutionalised elderly persons with or without dementia:: results from the Nordanstig cohort in the Kungsholmen Project -: a population based study in Sweden
Nordberg G; Wimo A; Jonsson L; Kareholt I; Sjolund B-M; Lagergren M; von Strauss E
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2007;22(5):485-491
Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease
Winblad B; Kawata AK; Beusterien KM; Thomas SK; Wimo A; Lane R; Fillit H; Blesa R
Article: ALZHEIMERS & DEMENTIA. 2007;3(2):81-91
An estimate of the total worldwide societal costs of dementia in 2005
Wimo A; Winblad B; Jonsson L
Article: EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. 2007;7(1):83-90
Cost-effectiveness of treatments for Alzheimer's dementia.
Wimo A; Norlund A
Article: ARCHIVES OF GERONTOLOGY AND GERIATRICS. 2007;44(1):71-81
Validity and reliability of assessments of time - Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD)-instrument
Wimo A; Nordberg G
Journal article: JOURNAL OF MENS HEALTH. 2006;3(4):373-378
Sense of coherence and vocational rehabilitation of persons with chronic musculoskeletal disorders–gender aspects
Kaiser P-O; Mattsson B; Marklund S; Wimo A
Journal article: ALZHEIMERS & DEMENTIA. 2006;2(3S_Part_1):s19-s20
O1–05–08: The worldwide directs costs and costs of informal care of dementia
Winblad B; Wimo A; Jönsson L
Journal article: ALZHEIMERS & DEMENTIA. 2006;2(3S_Part_5):s138-s139
P1–146: Dementia and community costs in an area with a dementia program targeting early intervention. A study with an economic focus
Jedenius E; Wimo A; Strömqvist J; Andreasen N
Article: JOURNAL OF NUTRITION HEALTH & AGING. 2006;10(4):255-262
Underweight, weight loss and related risk factors among older adults in sheltered housing - A Swedish follow-up study
Mamhidir AG; Ljunggren G; Kihlgren M; Kihlgren A; Wimo A
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2006;62(7):555-562
The use of angiotensin-converting enzyme inhibitors and other drugs with cardiovascular effects by non-demented and demented elderly with a clinical diagnosis of heart failure. A population-based study of the very old
Klarin I; Fastbom J; Wimo A
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2006;21(5):449-459
Determinants of costs of care for patients with Alzheimer's disease
Jonsson L; Jonhagen ME; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A
Article: LAKARTIDNINGEN. 2006;103(13):1022-1028
[There is a need to reform dementia care. Resources are not used optimally--time for evidence-based care].
Marcusson J; Hoffman W; Klingén S; Minthon L; Sandman PO; Strömqvist J; Sundin Y; Wahlund L-O; Wimo A
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2006;34(6):584-588
More illness and less disease? A 20-year perspective on chronic disease and medication
Hagstrom B; Mattsson B; Wimo A; Gunnarsson RK
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006;21(5-6):353-363
3-year study of donepezil therapy in Alzheimer's disease: Effects of early and continuous therapy
Winblad B; Wimo A; Engedal K; Soininen H; Verhey F; Waldemar G; Wetterholm A-L; Haglund A; Zhang R; Schindler R
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006;20(1):49-55
Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL
Jönsson L; Andreasen N; Kilander L; Soininen H; Waldemar G; Nygaard H; Winblad B; Jönhagen ME; Hallikainen M; Wimo A
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2006;21(3):175-181
An estimate of the worldwide prevalence and direct costs of dementia in 2003
Wimo A; Jonsson L; Winblad B
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2005;20(9):862-871
The amount of informal and formal care among non-demented and demented elderly persons -: Results from a Swedish population-based study
Nordberg G; von Strauss E; Kåreholt I; Johansson L; Wimo A
Journal article: ALZHEIMERS & DEMENTIA. 2005;1(1S_Part_3):s101
[O2‐04‐01]: The worldwide costs of dementia
Winblad B; Jönsson L; Wimo A
Article: DRUGS & AGING. 2005;22(1):69-82
The association of inappropriate drug use with hospitalisation and mortality - A population-based study of the very old
Klarin I; Wimo A; Fastbom J
Article: CURRENT MEDICAL RESEARCH AND OPINION. 2004;20(8):1221-1225
Impact of donepezil treatment for Alzheimer's disease on caregiver time
Wimo A; Winblad B; Shah SN; Chin W; Zhang R; McRae T
Article: SCANDINAVIAN JOURNAL OF CARING SCIENCES. 2004;18(2):169-176
Older patients awaiting emergency department treatment
Kihlgren AL; Nilsson M; Skovdahl K; Palmblad B; Wimo A
Article: AGING CLINICAL AND EXPERIMENTAL RESEARCH. 2004;16(2):158-168
A longitudinal study integrating population, care and social services data.: The Swedish National study on Aging and Care (SNAC)
Lagergren M; Fratiglioni L; Hallberg IR; Berglund J; Elmståhl S; Hagberg B; Holst G; Rennemark M; Sjölund BM; Thorslund M; Wiberg I; Winblad B; Wimo A
Article: EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. 2003;3(6):675-680
Pharmacoeconomic aspects of memantine (Ebixa) in the treatment of Alzheimer's disease.
Wimo A
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2003;12(8):669-678
A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: comparison with an urban cohort
Klarin I; Fastbom J; Wimo A
Article: HERNIA. 2003;7(3):114-117
Cost analysis of incisional hernia repair by suture or mesh.
Israelsson LA; Jönsson L; Wimo A
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003;17(2):63-67
The magnitude of dementia occurrence in the world
Wimo A; Winblad B; Aguero-Torres H; von Strauss E
Article: PHARMACOECONOMICS. 2003;21(5):327-340
Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease
Wimo A; Winblad B; Stoffler A; Wirth Y; Möbius HJ
Article: ACTA NEUROLOGICA SCANDINAVICA, SUPPLEMENT. 2003;107:94-99
Pharmacoeconomics of mild cognitive impairment
Wimo A; Winblad B
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2003;15(1):44-54
An economic evaluation of donepezil in mild to moderate Alzheimer's disease: Results of a 1-year, double-blind, randomized trial
Wimo A; Winblad B; Engedal K; Soininen H; Verhey F; Waldemar G; Wetterholm AL; Mastey V; Haglund A; Zhang R; Miceli R; Chin W; Subbiah P
Article: HEALTH POLICY. 2002;61(3):255-268
Time spent on informal and formal care giving for persons with dementia in Sweden
Wimo A; von Strauss E; Nordberg G; Sassi F; Johansson L
Article: PHARMACOECONOMICS. 2002;20(9):629-637
Assessment of health economics in Alzheimer's disease (AHEAD) - Treatment with galantamine in Sweden
Garfield FB; Getsios D; Caro JJ; Wimo A; Winblad B
Article: LAKARTIDNINGEN. 2001;98(38):4042-4048
Can the cost of future health care and social services needs of the elderly be calculated?
Wimo A; Jönsson L
Journal article: PSYCHOGERIATRICS. 2001;1(3):189-193
Health Economical Aspects of Alzheimer Disease and its Treatment
Wimo A; Winblad B
Article: NEUROLOGY. 2001;57(3):489-495
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
Winblad B; Engedal K; Soininen H; Verhey F; Waldemar G; Wimo A; Wetterholm AL; Zhang R; Haglund A; Subbiah P
Article: DISABILITY AND REHABILITATION. 2001;23(10):430-435
The impact of psychosocial 'markers' on the outcome of rehabilitation
Kaiser PO; Mattsson B; Marklund S; Wimo A
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2000;15(10):969-971
Assessment of informal services to demented people with the RUD instrument
Wimo A; Nordberg G; Jansson W; Grafström M
Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2000;10:368
Donepezil improved or stabilized cognition over one year in patients with mild and moderate Alzheimer's disease
Engedal K; Soininen H; Verhey F; Waldemar G; Winblad B; Wimo A; Wetterholm A-L; Zhang R; Haglund A; Subbiah P; Group TDNS
Article: BRITISH JOURNAL OF SURGERY. 2000;166(8):642-646
Cost minimisation analysis of change in closure technique of midline incisions
Israelsson LA; Wimo A
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2000;14(3):137-140
Second International Pharmacoeconomic Conference on Alzheimer's Disease
Jönsson L; Jönsson B; Wimo K; Whitehouse P; Winblad B
Article: LAKARTIDNINGEN. 2000;97(20):2489-2493
[Troubled times in care of the elderly. Increasing number of the "oldest old" and demented, shortage of general practitioners and lack of clarity with regards to locating resources].
Wimo A
Journal article: NEUROBIOLOGY OF AGING. 2000;21:275
Validation of time estimates of the RUD instrument in dementia care
Nordberg G; Grafstroem M; Winblad B; Wimo A
Journal article: NEUROBIOLOGY OF AGING. 2000;21:274
Benefits of donepezil on cognition, function and/or neuropsychiatric symptoms in patients with Alzheimer's disease over one year
Waldemar G; Winblad B; Engedal K; Soininen H; Verhey F; Wimo A; Zhang R; Subbiah P
Journal article: NEUROBIOLOGY OF AGING. 2000;21:63
An economic evaluation of donepezil in mild to moderate Alzheimer's disease: Results of a one-year, double-blind, randomized trial
Wimo A; Winblad B; Mastey V; Hertzman P; Haglund A; Miceli R; Jacobson L; Subbiah P
Journal article: NEUROBIOLOGY OF AGING. 2000;21:160-161
Response to donepezil is not predicted by apolipoprotein E genotype and/or gender
Soininen H; Winblad B; Engedal K; Waldemar G; Wimo A; Zhang R; Subbiah P
Journal article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1999;13:s9-19
Assessing the Societal Impact of Acetylcholinesterase Inhibitor Therapies
Winblad B; Wimo A
Article: PHARMACOECONOMICS. 1999;16(4):409-416
Costs of mini mental state examination-related cognitive impairment
Jönsson L; Lindgren P; Wimo A; Jönsson B; Winblad B
Article: CLINICAL THERAPEUTICS. 1999;21(7):1230-1240
The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease:: A Markov model
Jönsson L; Lindgren P; Wimo A; Jönsson B; Winblad B
Article: ARCHIVES OF GERONTOLOGY AND GERIATRICS. 1999;28(3):227-237
'Misplacement' of elderly people in the caring organisation:: reasons and alternatives
Wimo A; Rönnbäck E; Larsson B; Eriksson T; Eriksson IB; Thorslund M
Article: ARCHIVES OF GERONTOLOGY AND GERIATRICS. 1999;28(3):205-216
Nursing load in different care alternatives in Sweden during 18 years
Wimo A; Rönnbäck E; Nyberg A; Granholm O; Thorslund M
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1998;12(4):266-280
First International Pharmacoeconomic Conference on Alzheimer's Disease: Report and summary
Whitehouse PJ; Winblad B; Shostak D; Bhattacharjya A; Brod M; Brodaty H; Dor A; Feldman H; Forette F; Gauthier S; Hay J; Henke C; Hill S; Mastey V; Neumann P; O'Brien B; Pugner K; Sano M; Sawada T; Stone R; Wimo A
Article: CLINICAL THERAPEUTICS. 1998;20(3):552-566
Economic impact of introducing propentofylline for the treatment of dementia in Sweden
Wimo A; Witthaus E; Rother M; Winblad B
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1997;11(4):191-200
Treatment of Alzheimer disease with tacrine: A cost-analysis model
Wimo A; Karlsson G; Nordberg A; Winblad B
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1997;12(8):857-861
Cost of illness due to dementia in Sweden
Wimo A; Karlsson G; Sandman PO; Corder L; Winblad B
Article: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1997;11:39-45
Issues in the economic evaluation of treatment for dementia - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
Winblad B; Hill S; Beermann B; Post SG; Wimo A
Article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 1995;13(3):205-210
CARE FOR DEMENTED PATIENTS IN DIFFERENT LIVING-CONDITIONS
WIMO A; ADOLFSSON R; SANDMAN PO
Article: INTERNATIONAL PSYCHOGERIATRICS. 1995;7(1):123-127
Patients with dementia in group living: experiences 4 years after admission.
Wimo A; Asplund K; Mattsson B; Adolfsson R; Lundgren K
Article: NORDISK MEDICIN. 1995;110(4):123-126
[Care of patients with dementia--a ticking cost bomb?].
Wimo A; Karlsson G; Sandman PO; Winblad B
Article: INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 1995;11(1):49-65
COST-UTILITY ANALYSIS OF GROUP LIVING IN DEMENTIA CARE
WIMO A; MATTSON B; KRAKAU I; ERIKSSON T; NELVIG A; KARLSSON G
Journal article: HEALTH ECONOMICS. 1994;3(6):395-404
Cost-effectiveness analysis of day care for patients with dementia disorders.
Wimo A; Mattsson B; Krakau I; Eriksson T; Nelvig A
Journal article: LAKARTIDNINGEN. 1994;91(22):2206-2207
[12 points for better care for the aged].
Brydolf G; Wimo A
Journal article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1994;9(6):479-489
The impact of cognitive decline and workload on the costs of dementia care
Wimo A; Krakau I; Mattsson B; Nelvig A
Journal article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1993;8(8):675-679
Assessments of productivity of psychogeriatric day care
Wimo A; Ineichen B; Mattson B; Kallioinen M
Journal article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 1993;11(2):117-123
Dementia day care and its effects on symptoms and institutionalization--a controlled Swedish study.
Wimo A; Mattsson B; Adolfsson R; Eriksson T; Nelvig A
Journal article: INTERNATIONAL PSYCHOGERIATRICS. 1993;5(2):169-180
Can changes in ward routines affect the severity of dementia? A controlled prospective study.
Wimo A; Nelvig A; Nelvig J; Adolfsson R; Mattsson B; Sandman PO
Journal article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 1992;10(3):185-191
Predictive validity of factors influencing the institutionalization of elderly people with psycho-geriatric disorders.
Wimo A; Gustafsson L; Mattson B
Journal article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1991;6(1):21-29
Group living, an alternative for dementia patients. A cost analysis
Wimo A; Wallin JO; Lundgren K; Rönnbäck E; Asplund K; Mattsson B; Krakau I
Journal article: FAMILY PRACTICE. 1990;7(4):279-287
Impact of day care on dementia patients--costs, well-being and relatives' views.
Wimo A; Wallin JO; Lundgren K; Rönnbäck E; Asplund K; Mattsson B; Krakau I
Journal article: LAKARTIDNINGEN. 1990;87(25):2175-2178
[Future geriatric care demands expanded capacity of small institutional units].
Wimo A; Lundkvist B; Strömberg G; Rönnbäck E; Ostman A; Backlund L; Brydolf G; Lundvall O
Journal article: LAKARTIDNINGEN. 1990;87(18):1555-1556
[Aggression and motor problems force persons with dementia to leave group dwellings].
Asplund K; Wimo A; Lundgren K
Journal article: LAKARTIDNINGEN. 1988;85(48):4202-4207
[A cross-sectional study in Sundsvall. 90-year-old persons are healthier than expected. The majority live in their own flats].
Wimo A; Strömberg E; Elfving G; Brydolf G
Visa fler

Alla övriga publikationer

Preprint: MEDRXIV. 2024
New IPECAD open-source model framework for the health technology assessment of early Alzheimer’s disease treatment: development and use cases
Handels R; Herring WL; Grimm S; Sköldunger A; Winblad B; Wimo A; Jönsson L
Review: JOURNAL OF INTERNAL MEDICINE. 2024;295(3):281-291
People get ready! A new generation of Alzheimer's therapies may require new ways to deliver and pay for healthcare
Wahlberg K; Winblad B; Cole A; Herring WL; Ramsberg J; Torontali I; Visser P-J; Wimo A; Wollaert L; Jonsson L
Review: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2024;11(5):1212-1218
Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) Investigators.
Jessen F; Kramberger MG; Angioni D; Aarsland D; Balasa M; Bennys K; Boada M; Boban M; Chincarini A; Exalto L; Felbecker A; Fliessbach K; Frisoni GB; Garza-Martínez AJ; Grimmer T; Hanseeuw B; Hort J; Ivanoiu A; Klöppel S; Krajcovicova L; McGuinness B; Mecocci P; de Mendonca A; Nous A; Ousset P-J; Paquet C; Perneczky R; Peters O; Tabuas-Pereira M; Piazza F; Plantone D; Riverol M; Ruiz A; Sacco G; Santana I; Scarmeas N; Solje E; Stefanova E; Sutovsky S; van der Flier W; Welsh T; Wimo A; Winblad B; Frölich L; Engelborghs S
Editorial comment: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2024;11(4):895-896
On the 2024 Alzheimer's Association Criteria: Still Not Ready for Clinical Use
Zhou RZ; Wimo A; Winblad B
Conference publication: VALUE IN HEALTH. 2023;26(12):s1
P3 Open-Source Model Framework for Health-Economic Evaluation of Early Treatment in Alzheimer's Disease
Handels R; Wimo A; Skoldunger A; Tate A; Winblad B; Silvertand D; Nguyen L; Jönsson L; Grimm S; Aye S; Herring W
Letter: ALZHEIMERS & DEMENTIA. 2023;19(10):4760-4763
Response to "Comment on 'Dementia prevention: The potential long-term cost-effectiveness of the FINGER prevention program'"
Wimo A; Handels R; Antikainen R; Eriksdotter M; Jonsson L; Knapp M; Kulmala J; Laatikainen T; Lehtisalo J; Peltonen M; Skoldunger A; Soininen H; Solomon A; Strandberg T T; Tuomilehto J; Ngandu T; Kivipelto M
Conference publication: VALUE IN HEALTH. 2023;26(12):S1
OPEN-SOURCE MODEL FRAMEWORK FOR HEALTH-ECONOMIC EVALUATION OF EARLY TREATMENT IN ALZHEIMER'S DISEASE
Handels R; Wimo A; Skoldunger A; Tate A; Winblad B; Silvertand D; Nguyen L; Jonsson L; Grimm S; Aye S; Herring W
Editorial comment: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2023;10(3):349-352
Amyloid-targeting New Therapies for Alzheimer's Disease: A Health Economics Perspective
Jonsson L; Wimo A
Review: PHARMACOECONOMICS. 2023;41(1):59-75
The Costs of Dementia in Europe: An Updated Review and Meta-analysis
Jonsson L; Tate A; Frisell O; Wimo A
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2022;29:74
The COVID-19 pandemic has caused large disruptions to dementia mortality, care, and diagnosis in Sweden during 2020
Winblad B; Schedin-Weiss S; Tjernberg L; Wimo A; Bucht G; Eriksdotter M; Axenhus M
Editorial comment: EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. 2021;21(1):1-4
What are the difficulties of implementing innovative pharmacy practice models in the care of patients with dementia?
Wimo A
Editorial comment: INTERNATIONAL PSYCHOGERIATRICS. 2020;32(5):1-6
Time to invest in prevention and better care of behaviors and psychological symptoms associated with dementia
Burley CV; Livingston G; Knapp MRJ; Wimo A; Norman R; Brodaty H
Review: AGING & MENTAL HEALTH. 2020;24(2):200-211
Interventions to enhance access to and utilization of formal community care services for home dwelling persons with dementia and their informal carers. A scoping review
Rosvik J; Michelet M; Engedal K; Bieber A; Broda A; Goncalves-Pereira M; Hopper L; Irving K; Jelley H; Kerpershoek L; Meyer G; Marques MJ; Portolani E; Sjolund B-M; Skoldunger A; Stephan A; Verhey F; de Vugt M; Woods B; Wolfs C; Zanetti O; Selbaek G; Handels R; Bartoszek G; Orrell M; Wimo A; Eriksen S; Joyce R; Balsinha MC; Machado A
Review: ALZHEIMERS & DEMENTIA. 2019;15(6):828-839
The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community
Rodriguez-Gomez O; Rodrigo A; Iradier F; Santos-Santos MA; Hundemer H; Ciudin A; Sannemann L; Zwan M; Glaysher B; Wimo A; Bonn J; Johansson G; Rodriguez I; Alegret M; Gove D; Pino S; Trigueros P; Kivipelto M; Mathews B; Ciudad A; Ferreira D; Bintener C; Gurruchaga M; Westman E; Belger M; Valero S; Maguire P; Krivec D; Kramberger M; Simo R; Garro IP; Visser PJ; Dumas A; Georges J; Jessen F; Winblad B; Shering C; Stewart N; Campo L; Boada M
Conference publication: EUROPEAN PSYCHIATRY. 2017;41:S652
The Portuguese participation in the Actifcare (access to timely formal care in dementia) European study: Preliminary results of systematic reviews, qualitative and quantitative data
Goncalves-Pereira M; Marques MJ; Balsinha C; Reis T; Machado A; Barrios H; Alves L; Verdelho A; Meyer G; Woods B; Wimo A; Selbaeck G; Irving K; Zanetti O; Orrell M; De Vugt M; Verhey F
Corrigendum: ALZHEIMERS RESEARCH & THERAPY. 2017;9(1):12
The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care (vol 8, 59, 2016)
Wimo A; Jonsson L; Fratiglioni L; Sandman PO; Gustavsson A; Skoldunger A; Johansson JL
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2017;24:528
Estimates of health-care and societal costs as a function of pre-institutionalisation time in patients with Alzheimer's disease dementia
Reed C; Belger M; Haro JM; Dell'Agnello G; Wimo A
Meeting abstract: VALUE IN HEALTH. 2016;19(7):A377
CURRENT ISSUES AND FUTURE RESEARCH PRIORITIES FOR HEALTH ECONOMIC MODELLING OF AT RISK POPULATION FOR ALZHEIMER'S DISEASE/DEMENTIA
Gustavsson A; Green C; Jones RW; Simsek D; de Vulpillieres DRF; Adlard N; Bhattacharyya S; Wimo A; ForstlFoerstl H; Luthman S
Corrigendum: BMC HEALTH SERVICES RESEARCH. 2016;16(1):620
Access to timely formal dementia care in Europe: protocol of the Actifcare (ACcess to Timely Formal Care) study(vol 16, 423, 2016)
Kerpershoek L; de Vugt M; Wolfs C; Jelley H; Orrell M; Woods B; Stephan A; Bieber A; Meyer G; Engedal K; Selbaek G; Handels R; Wimo A; Hopper L; Irving K; Marques M; Goncalves-Pereira M; Portolani E; Zanetti O; Verhey F
Conference publication: GERONTOLOGIST. 2016;56:389
COGNITIVE IMPAIRMENT AND RESOURCE USE IN SWEDISH NURSING HOMES: RESULTS FROM THE SVENIS STUDY
Skldunger AB; Wimo A; Sandman P; Backman A; Edvardsson D
Editorial comment: LANCET NEUROLOGY. 2015;14(12):1145-1146
Long-term effects of Alzheimer's disease treatment
Wimo A
Conference publication: VALUE IN HEALTH. 2015;18(7):A759-A760
COMPARING RESOURCE USE IN ALZHEIMER'S DISEASE ACROSS THREE EUROPEAN COUNTRIES-18-MONTH RESULTS OF THE GERAS STUDY
Belger M; Arigmon JM; Dodel R; Haro JM; Wimo A; Reed C
Conference publication: VALUE IN HEALTH. 2015;18(7):A760
HOW USEFUL ARE EQ-5D AND ZBI IN ASSESSING THE IMPACT OF CARING FOR ALZHEIMER'S DISEASE PATIENTS?
Reed C; Barrett A; Lebrec J; Dodel R; Jones RW; Vellas B; Wimo A; Argimon JM; Bruno G; Haro JM
Editorial comment: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2015;16(9):720-721
Brain Health: A Primary Health Care Viewpoint
Wimo A; Winblad B
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2015;27:S34-S35
Access to formal dementia care: Results from a systematic review and a European focus group study
Stephan A; Verhey F; de Vugt M; Wolfs C; Handels R; Verbeek H; Kerpershoek L; Bieber A; Meyer G; Pereira MG; Marques M; Barrios H; Balsinha C; Woods R; Wimo A; Selbaeck G; Irving K; Zanetti O
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2015;27:S35-S36
Access to timely care in Portugal as compared to other European countries
Pereira MG; Stephan A; Verhey F; de Vugt M; Wolfs C; Handels R; Verbeek H; Kerpershoek L; Bieber A; Meyer G; Marques M; Barrios H; Balsinha C; Woods R; Wimo A; Selbaeck G; Irving K; Zanetti O
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2015;27:S34
Background and rationale of the Actifcare project
Verhey F; de Vugt M; Wolfs C; Handels R; Verbeek H; Kerpershoek L; Stephan A; Bieber A; Meyer G; Pereira MG; Marques M; Barrios H; Balsinha C; Woods R; Wimo A; Selbaeck G; Irving K; Zanetti O
Conference publication: VALUE IN HEALTH. 2014;17(3):A185
HOW TO DEAL WITH MISSING LONGITUDINAL DATA IN COST OF ILLNESS MODELS IN ALZHEIMER'S DISEASE - SUGGESTIONS FROM THE GERAS STUDY RESULTS
Belger M; Haro JM; Reed C; Happich M; Kahle-Wrobleski K; Wimo A
Review: ALZHEIMERS & DEMENTIA. 2013;9(1):63-75.e2
The global prevalence of dementia: A systematic review and metaanalysis
Prince M; Bryce R; Albanese E; Wimo A; Ribeiro W; Ferri CP
Conference publication: VALUE IN HEALTH. 2012;15(7):A554
HEALTH STATE VALUES IN ALZHEIMER'S DISEASE - BASELINE RESULTS FROM A LARGE PROSPECTIVE OBSERVATIONAL STUDY IN THREE EUROPEAN COUNTRIES (GERAS)
Reed C; Argimon J; Belger MA; Bruno G; Dodel R; Happich M; Haro JM; Jones RW; Vellas B; Wimo A
Conference publication: VALUE IN HEALTH. 2012;15(7):A527
HEALTH CARE RESOURCE USE AND COST IN ALZHEIMER'S DISEASE IN THREE EUROPEAN COUNTRIES - BASELINE FINDINGS OF THE GERAS STUDY
Reed C; Argimon J; Belger MA; Bruno G; Dodel R; Happich M; Haro JM; Jones RW; Vellas B; Wimo A
Conference publication: NEUROBIOLOGY OF AGING. 2012;33:S36
GLOBAL PHARMACOECONOMICS OF ALZHEIMER'S DISEASE IN LIGHT OF POTENTIAL COST EFFECTIVENESS OF DISEASE MODIFYING TREATMENT
Wimo A
Conference publication: VALUE IN HEALTH. 2011;14(7):a289
MORTALITY IN RELATION TO DISEASE SEVERITY IN SUBJECTS WITH DEMENTIA
Jonsson L; Fratiglioni L; Wimo A
Book chapter: PRINCIPLES AND PRACTICE OF GERIATRIC PSYCHIATRY. 2010;p. 90-96
Economics of Ageing and Mental Health
Wimo A
Editorial comment: JOURNAL OF ALZHEIMERS DISEASE. 2010;19(2):617-619
The Art of Cost of Illness
Wimo A
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2010;17:75
Age affects quality and cost of dementia diagnosis
Religa D; Spangberg K; Wimo A; Jonsson L; Edlund A-K; Winblad B; Jonhagen ME
Other: LAKARTIDNINGEN. 2009;106(49):3357
[Diagnosis of dementia in the elderly is not unnecessary].
Jönhagen ME; Edlund A-K; Eriksson S; Granqvist N; Kilander L; Mattson U-B; Nelvig A; Nägga K; Wimo A; Winblad B
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2009;16:358
The lower cost of dementia diagnosis in women
Religa D; Spangberg K; Wimo A; Jonsson L; Edlund A-K; Johansson N; Winblad B; Eriksdotter MJ
Review: PHARMACOECONOMICS. 2009;27(5):391-403
The Cost of Dementia in Europe A Review of the Evidence, and Methodological Considerations
Jonsson L; Wimo A
Review: LANCET NEUROLOGY. 2008;7(9):812-826
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
Kalaria RN; Maestre GE; Arizaga R; Friedland RP; Galasko D; Hall K; Luchsinger JA; Ogunniyi A; Perry EK; Potocnik F; Prince M; Stewart R; Wimo A; Zhang Z-X; Antuono P
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2008;15:222
The SERAD study: galantamine improves cognitive function in nursing home patients with severe Alzheimer's disease
Burns A; Bernabei R; Bullock R; Jentoft AJC; Frolich L; Hock C; Triau E; Vandewoude M; Wimo A; Came E; Van Baelen B; van Oene JC; Schwalen S
Editorial comment: ALZHEIMERS & DEMENTIA. 2007;3(3):157-161
Commentary on "Health economics and the value of therapy in Alzheimer's disease." Cost-effectiveness studies
Wimo A; Norlund A
Published conference paper: INTERNATIONAL PSYCHOGERIATRICS. 2007;19(3):497-507
Clinical and economic outcomes - friend or foe?
Wimo A
Book chapter: SEVERE DEMENTIA. 2006;p. 227-236
Health Economics of Severe Dementia
Wimo A; Winblad B
Conference publication: NEUROBIOLOGY OF AGING. 2006;27:S23
Cholinesterase inhibitors for AD therapy: Are they worth the price?
Wimo A
Corrigendum: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006;20(2):125
Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL. (vol 20, pg 49, 2006)
Jonsson L; Andreasen N; Kilander L; Soininen H; Waldemar G; Nygaard H; Winblad B; Eriksdotter JM; Hallikainen M; Wimo A
Book chapter: STANDARDS IN DEMENTIA CARE. 2005;p. 326-333
Government perspectives England
Wimo A
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2005;17:334-335
The amount of informal and formal care among non-demented and demented elderly persons - Result from a Swedish population based study
Nordberg G; von Strauss E; Kareholt I; Johansson L; Wimo A
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2005;17:34-35
Treatment with glutamatergic antagonists: current pharmacoeconomic data
Wimo A
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2005;17:8
Are treatments for dementia worth it? A health economic perspective
Wimo A
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2005;17:337-338
SveDem, how do you do, Sweden?
Spangberg K; Jonhagen ME; Fratiglioni L; Graff C; Minthon L; Sandman PO; Wimo A; Marcusson J; Eriksson S; Johansson G; Winblad B
Meeting abstract: NEUROBIOLOGY OF AGING. 2004;25:s346
Societal costs of dementia in Sweden:: An application of the rud-instrument in a population-based study
Wimo AB; Winblad B; Nordberg G; von Stauss E; Sjölund BM
Conference publication: NEUROBIOLOGY OF AGING. 2004;25:S28
From resource utilization to costs: How and how much and why?
Wimo A
Review: DRUGS & AGING. 2004;21(5):279-295
Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease - A review with methodological considerations
Wimo A
Review: CURRENT PHARMACEUTICAL DESIGN. 2004;10(3):295-301
Economic aspects on drug therapy of dementia
Wimo A; Winblad B
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2003;13:S404
Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study
Winblad B; Wimo A; Wetterholm AL; Haglund A; Engedal K; Soininen H; Verhey FRJ; Waldemar G; Zhang R; Burger L; Schindler R
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2003;13:S402-S403
Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a-one-year placebo-controlled study and participated in a two-year follow-up study
Winblad B; Engedal K; Soininen H; Verhey FRJ; Waldemar G; Wimo A; Wetterholm AL; Haglund A; Zhang R; Burger L; Schindler R
Meeting abstract: VALUE IN HEALTH. 2003;6(3):276
Caregiver health benefits and associated reductions in healthcare costs as a consequence of treating patients with donepezil
Winblad B; Wimo A; Mastey V; Shah S; Haglund A; Zhang R; Miceli R; Chin W
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:322
Donepezil treatment in Alzheimer's disease patients: Caregiver health benefits and associated reductions in healthcare costs
Wimo A; Winblad B; Shah S; Haglund A; Zhang R; Chin W
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:293-294
Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study
Winblad B; Engedal K; Soininen H; Waldemar G; Verhey F; Wimo A; Wetterholm AL; Haglund A; Zhang R; Burger L; Schindler R
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:292-293
Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a one-year placebo-controlled study and participated in a two-year follow-up study
Winblad B; Engedal K; Soininen H; Verhey F; Waldemar G; Wimo A; Wetterholm AL; Zhang R; Burger L; Schindler R
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:149
Cost effectiveness of treatments of dementia
Winblad B; Wimo A
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:320-321
Comparison of dementia prevalence in an urban and a rural population in Sweden:: Data from the Kungsholmen-Nordanstig project
Von Strauss EI; Nordberg GK; Sjölund BM; Wimo A
Conference publication: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:155
Comorbidity and costs of dementia
Wimo A; Klarin I; Sjolund BM; Von Strauss EI
Published conference paper: INTERNATIONAL PSYCHOGERIATRICS. 2003;15:251-256
Societal burden and economics of vascular dementia: Preliminary results from a Swedish-population-based study
Wimo A; Winblad B
Book chapter: DEMENTIA. 2002;p. 341-387
Costs of Dementia: A Review
Jönsson B; Jönsson L; Wimo A
Conference publication: NEUROBIOLOGY OF AGING. 2002;23(1):S144-S145
Pharmacoeconomics and dementia
Wimo A
Book chapter: ALZHEIMER'S DISEASE. 2001;p. 725-738
Benefits of Donepezil on Cognition, Function and Neuropsychiatric Symptoms in Patients with Mild and Moderate Alzheimer's Disease over One Year
Waldemar G; Winblad B; Engedal K; Soininen H; Verhey F; Wimo A; Wetterholm A; Zhang R; Haglund A; Subbiah P
Conference publication: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2001;49(4):S131
An economic evaluation of donepezil in mild to moderate Alzheimer's disease: Results of a one-year, double-blind, randomized trial.
Mastey V; Wimo A; Winblad B; Haglund A; Jacobson L; Miceli R; Zhang R; Subbiah P
Conference publication: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2001;49(4):S20
Donepezil reduces the time caregivers spend providing care: Results of a one-year, double-blind randomized trial in patients with mild to moderate Alzheimer's disease.
Mastey V; Wimo A; Winblad B; Haglund A; Jacobson L; Miceli R; Zhang R; Subbiah P
Published conference paper: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2000;11:3-10
Outcome measures in Alzheimer's disease: Do they go far enough?
Winblad B; Wimo A; Almkvist O
Book chapter: DEMENTIA. 2000;p. 335-381
Costs of Dementia: A Review
Jönsson B; Jönsson L; Wimo A
Conference publication: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2000;48(8):S107
Long-term benefits of donepezil on ADLs in AD patients.
Soininen H; Winblad B; Engedal K; Verhey F; Wimo A; Wetterholm AL; Zhang R; Haglund A; Subbiah P
Editorial comment: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1999;14(11):911-914
Severe dementia:: A common condition entailing high costs at individual and societal levels
Winblad B; Wimo A; Möbius HJ; Fox JM; Fratiglioni L
Published conference paper: ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1999;13:S9-19
Assessing the societal impact of acetylcholinesterase inhibitor therapies
Winblad B; Wimo A
Review: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1999;14(5):338-347
The social consequences for families with Alzheimer's disease patients: Potential impact of new drug treatment
Wimo A; Winblad B; Grafstrom M
Review: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 1997;12(8):841-856
Costs of dementia and dementia care: A review
Wimo A; Ljunggren G; Winblad B
Letter: LAKARTIDNINGEN. 1996;93(13):1200
[More accurate diagnosis could identify patients suitable for tacrine therapy].
Andreasen N; Eriksson S; Karlsson I; Lindahl B; Lund M; Nordberg A; Wimo A; Winblad B; Astrand R
Published conference paper: ACTA NEUROLOGICA SCANDINAVICA, SUPPLEMENT. 1996;94:101-104
What are the costs to society and to individuals regarding diagnostic procedures and care of patients with dementia?
Winblad B; Ljunggren G; Karlsson G; Wimo A
Visa fler

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI